Fundamental leadership · SEC EDGAR · no analyst estimates · as of 2026-07-20
Which industries lead on earnings and sales, today. As of 2026-07-20, 4,463 companies clear the eligibility gates and 1,339 rank Leader or Strong on filed EPS and revenue growth. The strongest industry group is Precious Metals with 29 Leader or Strong names. 19.4% of eligible companies also sit in the top relative-strength quintile — fundamentals and price agreeing.
Sector
| Ticker | Company | Rank | Δ3wk | Verdict | EPS YoY | Sales YoY | Margin Δ | 6M RS | Filed |
|---|---|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corporation Common Stock | 99 | ±0 | Leader | to profit↑ | >+999%↑ | — | 46 | 2026-05-13 |
| NIVF | NewGenIvf Group Limited Class A ordinary shares | 99 | ±0 | Leader | to profit | >+999% | — | 2 | 2026-03-31 |
| ORMP | Oramed Pharmaceuticals Inc. | 99 | ±0 | Leader | to profit | — | — | 68 | 2026-05-19 |
| PALI | Palisade Bio, Inc. Common Stock | 99 | ±0 | Leader | loss narrowed 89% | — | — | 66 | 2026-05-12 |
| QTTB | Q32 Bio Inc. Common Stock | 99 | ±0 | Leader | loss narrowed 40% | — | — | 99 | 2026-05-05 |
| SLGL | Sol-Gel Technologies Ltd. Ordinary Shares | 99 | ±0 | Leader | >+999% | +218% | — | 74 | 2026-03-19 |
| ZVRA | Zevra Therapeutics, Inc. Common Stock | 99 | +1 | Leader | to profit↑ | +78%↓ | >+10,000 bps | 86 | 2026-05-06 |
| BCRX | BioCryst Pharmaceuticals Inc | 98 | ±0 | Leader | to loss | +7% | -4970 bps | 82 | 2026-05-06 |
| CGEN | Compugen Ltd | 98 | ±0 | Leader | to profit | +161% | +9649 bps | 68 | 2026-03-02 |
| LKFT | Lakefront Biotherapeutics American Depositary Shares | 98 | ±0 | Leader | +335% | +304% | +9485 bps | — | 2026-03-26 |
| LQDA | Liquidia Corporation Common StockBiotech & Genomics | 98 | ±0 | Leader33 | to profit↑ | >+999%↑ | >+10,000 bps | 97 | 2026-05-11 |
| SPRO | Spero Therapeutics, Inc. Common Stock | 98 | ±0 | Leader | loss narrowed 48% | -100% | — | 17 | 2026-05-13 |
| TBPH | Theravance Biopharma, Inc. | 98 | ±0 | Leader | loss narrowed 63% | +15% | +7811 bps | 35 | 2026-05-07 |
| TMDX | TransMedics Group, Inc. Common Stock | 98 | ±0 | Leader | -71% | +21%↓ | +409 bps | 12 | 2026-05-05 |
| ANAB | AnaptysBio, Inc. Common Stock | 97 | ±0 | Leader | loss widened 44% | -8%↓ | >+10,000 bps | 65 | 2026-05-12 |
| ARQT | Arcutis Biotherapeutics, Inc. Common Stock | 97 | ±0 | Leader | loss narrowed 55% | +65%↓ | +5887 bps | 60 | 2026-05-06 |
| AUPH | Aurinia Pharmaceuticals Inc | 97 | ±0 | Leader | +56% | +24% | +2944 bps | 58 | 2026-05-07 |
| BEAM | Beam Therapeutics Inc. Common StockBiotech & Genomics | 97 | ±0 | Leader | loss narrowed 27% | +325%↑ | >+10,000 bps | 34 | 2026-05-07 |
| ETON | Eton Pharmaceutcials, Inc. Common Stock | 97 | ±0 | Leader | to profit | +40%↓ | +704 bps | 98 | 2026-05-14 |
| NBIX | Neurocrine Biosciences IncBiotech & Genomics | 97 | ±0 | Leader | >+999% | +42%↑ | +492 bps | 84 | 2026-05-05 |
| OMER | Omeros Corporation | 97 | ±0 | Leader | to profit | — | — | 30 | 2026-05-13 |
| RADX | Radiopharm Theranostics Limited American Depositary Shares | 97 | ±0 | Leader | loss narrowed 86% | >+999% | — | 34 | 2025-09-18 |
| TGTX | TG Therapeutics, Inc.Biotech & Genomics | 97 | ±0 | Leader | +300% | +70%↓ | +586 bps | 95 | 2026-05-06 |
| BLLN | BillionToOne, Inc. Class A Common Stock | 96 | ±0 | Leader | to profit | +100% | — | 85 | 2026-05-06 |
| CAI | Caris Life Sciences, Inc. Common Stock | 96 | +1 | Leader | to profit | +79% | — | 16 | 2026-05-08 |
| PLX | Protalix BioTherapeutics, Inc. Common Stock | 96 | ±0 | Leader | to profit | +234% | +1817 bps | 74 | 2026-05-13 |
| RANI | Rani Therapeutics Holdings, Inc. Class A Common Stock | 96 | +1 | Leader | loss narrowed 82% | +893%↑ | — | 12 | 2026-05-15 |
| RIGL | Rigel Pharmaceuticals Inc. (New) | 96 | ±0 | Leader | -30% | +10%↓ | +1993 bps | 61 | 2026-05-05 |
| XERS | Xeris Biopharma Holdings, Inc. Common Stock | 96 | ±0 | Leader | to profit | +38% | +2151 bps | 73 | 2026-05-07 |
| BMEA | Biomea Fusion, Inc. Common Stock | 95 | ±0 | Leader | loss narrowed 79% | — | — | 46 | 2026-05-11 |
| CRMD | CorMedix Inc. | 95 | +1 | Leader | +43% | +226% | — | 68 | 2026-05-14 |
| GMED | GLOBUS MEDICAL INC | 95 | ±0 | Leader | +67% | +27%↑ | +704 bps | 32 | 2026-05-07 |
| GTBP | GT Biopharma Inc. Common Stock | 95 | ±0 | Leader | loss narrowed 67% | — | — | 10 | 2026-05-15 |
| KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | 95 | ±0 | Leader | +145% | +56% | +1565 bps | 94 | 2026-04-28 |
| PMCB | PharmaCyte Biotech, Inc. Common Stock | 95 | ±0 | Leader | loss narrowed 61% | — | — | 21 | 2026-03-17 |
| PODD | Insulet Corporation | 95 | ±0 | Leader | +160% | +34%↑ | +198 bps | 16 | 2026-05-06 |
| SI | Shoulder Innovations, Inc. | 95 | ±0 | Leader | loss narrowed 99% | +65% | — | 92 | 2026-05-13 |
| SNWV | SANUWAVE Health, Inc. Common Stock | 95 | ±0 | Leader | loss narrowed 76% | +3% | -1238 bps | 5 | 2026-05-12 |
| ANIP | ANI Pharmaceuticals, Inc. | 94 | ±0 | Leader | +86% | +20%↓ | +1244 bps | 43 | 2026-05-08 |
| ARGX | argenx SE American Depositary Shares | 94 | ±0 | Leader | +53% | +254% | — | 60 | 2026-03-19 |
| ASMB | Assembly Biosciences, Inc | 94 | ±0 | Leader | loss narrowed 54% | -13% | — | 35 | 2026-05-07 |
| DTIL | Precision BioSciences, Inc. Common Stock | 94 | ±0 | Leader | loss narrowed 66% | >+999%↑ | -57 bps | 96 | 2026-05-05 |
| ECVT | Ecovyst Inc. | 94 | ±0 | Leader | to profit↑ | +50% | -225 bps | 72 | 2026-05-05 |
| EVAX | Evaxion A/S American Depositary Share | 94 | ±0 | Leader | loss narrowed 90% | +125% | — | 18 | 2026-03-05 |
| EVMN | Evommune, Inc. | 94 | ±0 | Leader | loss narrowed 75% | +86% | — | 17 | 2026-05-07 |
| IRTC | iRhythm Holdings, Inc. Common Stock | 94 | ±0 | Leader | loss narrowed 56% | +26%↓ | +1256 bps | 20 | 2026-04-30 |
| LGND | Ligand Pharmaceuticals Inc. | 94 | ±0 | Leader | loss narrowed 70%↓ | +14%↓ | +6852 bps | 91 | 2026-05-08 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 94 | ±0 | Leader | to profit | >+999% | >+10,000 bps | 96 | 2026-05-07 |
| LXU | LSB INDUSTRIES INC | 94 | ±0 | Leader | to profit↑ | +18%↓ | +1418 bps | 71 | 2026-04-30 |
| OMDA | Omada Health, Inc. Common Stock | 94 | +1 | Leader | loss narrowed 96% | +42% | — | 92 | 2026-05-08 |
| PRTA | Prothena Corporation plc Ordinary Shares | 94 | ±0 | Leader | to profit↑ | >+999% | <-10,000 bps | 46 | 2026-05-07 |
| TER | Teradyne, Inc. Common StockSemiconductorsRobotics & Automation | 94 | ±0 | Leader33 | +315%↑ | +87%↑ | +455 bps | 90 | 2026-05-01 |
| TNON | Tenon Medical, Inc. Common Stock | 94 | ±0 | Leader | to profit↑ | +90% | — | 4 | 2026-05-15 |
| ALVO | Alvotech Ordinary Shares | 93 | ±0 | Leader | to profit | +20% | -88 bps | 23 | 2026-03-31 |
| BBNX | Beta Bionics, Inc. Common Stock | 93 | ±0 | Leader | loss narrowed 47% | +57%↓ | +783 bps | 54 | 2026-04-21 |
| CARL | Carlsmed, Inc. Common Stock | 93 | ±0 | Leader | loss narrowed 78% | +58% | — | 35 | 2026-05-05 |
| CDXS | Codexis, Inc. | 93 | ±0 | Leader | loss narrowed 60% | +102%↑ | +9722 bps | 80 | 2026-05-07 |
| COHR | Coherent Corp.AI Infrastructure | 93 | ±0 | Leader | to profit | +21%↑ | +371 bps | 90 | 2026-05-06 |
| FDMT | 4D Molecular Therapeutics, Inc. Common Stock | 93 | ±0 | Leader | loss widened 17% | >+999% | — | 90 | 2026-05-07 |
| HTFL | Heartflow, Inc. Common Stock | 93 | ±0 | Leader | loss narrowed 94% | +41% | — | 22 | 2026-05-14 |
| LLY | Eli Lilly & Co.GLP-1 / Obesity | 93 | ±0 | Leader | +170% | +56% | +1533 bps | 68 | 2026-04-30 |
| LUCD | Lucid Diagnostics Inc. Common Stock | 93 | ±0 | Leader | loss narrowed 67% | +52%↑ | — | 30 | 2026-05-13 |
| ONC | BeOne Medicines Ltd. American Depositary Shares | 93 | ±0 | Leader | to profit↓ | +35% | +1903 bps | 44 | 2026-05-06 |
| VCYT | Veracyte, Inc.Biotech & Genomics | 93 | ±0 | Leader | +289% | +21%↑ | +919 bps | 88 | 2026-05-06 |
| ADAG | Adagene Inc. American Depositary Shares | 92 | ±0 | Leader | loss narrowed 49% | >+999% | — | 96 | 2026-04-01 |
| ALNY | Alnylam Pharmaceuticals, Inc.Biotech & Genomics | 92 | ±0 | Leader | loss narrowed 73%↑ | +85% | +2137 bps | 28 | 2026-04-30 |
| BTSG | BrightSpring Health Services, Inc. Common Stock | 92 | ±0 | Leader | +379% | +26%↑ | +53 bps | 95 | 2026-05-01 |
| JAGX | Jaguar Health, Inc. | 92 | ±0 | Leader | loss narrowed 19% | +816% | >+10,000 bps | 2 | 2026-05-20 |
| PHAT | Phathom Pharmaceuticals, Inc. Common Stock | 92 | ±0 | Leader | loss narrowed 72% | +104% | >+10,000 bps | 24 | 2026-04-30 |
| SCYX | SCYNEXIS, Inc. | 92 | ±0 | Leader | loss widened 282% | -100% | — | 28 | 2026-05-11 |
| TARS | Tarsus Pharmaceuticals, Inc. Common Stock | 92 | ±0 | Leader | loss narrowed 75%↑ | +107%↓ | +3722 bps | 29 | 2026-05-06 |
| TVTX | Travere Therapeutics, Inc. Common Stock | 92 | ±0 | Leader | loss narrowed 15%↓ | +56%↓ | +7244 bps | 96 | 2026-05-04 |
| AGEN | Agenus Inc. | 91 | ±0 | Leader | to profit | +40%↑ | >+10,000 bps | 86 | 2026-05-11 |
| ALGS | Aligos Therapeutics, Inc. Common Stock | 91 | ±0 | Leader | loss widened 5% | +810% | — | 19 | 2026-05-07 |
| ATHE | Alterity Therapeutics Limited American Depositary Shares | 91 | +1 | Leader | loss narrowed 63% | +89% | — | 89 | 2025-08-29 |
| INDV | Indivior Pharmaceuticals, Inc. Common Stock | 91 | ±0 | Leader | +82% | +19% | +2385 bps | 76 | 2026-04-30 |
| LFST | LifeStance Health Group, Inc. Common Stock | 91 | ±0 | Leader | to profit | +21%↑ | +403 bps | 92 | 2026-05-07 |
| MGTX | MeiraGTx Holdings plc Ordinary Shares | 91 | ±0 | Leader | loss widened 12% | -85% | >+10,000 bps | 93 | 2026-05-14 |
| NTRA | Natera, Inc. Common Stock | 91 | ±0 | Leader | loss widened 20% | +39% | -56 bps | 66 | 2026-05-08 |
| RLYB | Rallybio Corporation Common Stock | 91 | +41 | Leader | loss narrowed 14%↓ | 0% | — | 99 | 2026-05-13 |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | 91 | ±0 | Leader | loss narrowed 56% | -56% | +7876 bps | 18 | 2026-05-06 |
| TLSI | TriSalus Life Sciences, Inc. Common Stock | 91 | ±0 | Leader | to profit↑ | -3% | +3656 bps | 24 | 2026-05-12 |
| AORT | Artivion, Inc. | 90 | ±0 | Leader | to profit | +18% | +412 bps | 17 | 2026-05-08 |
| AVAH | Aveanna Healthcare Holdings Inc. Common Stock | 90 | ±0 | Leader | +533%↑ | +16% | +363 bps | 52 | 2026-05-14 |
| BGMS | Bio Green Med Solution, Inc. Common Stock | 90 | ±0 | Leader | loss narrowed 100% | — | — | 19 | 2026-05-15 |
| FEMY | Femasys Inc. Common Stock | 90 | ±0 | Leader | to profit | +25% | — | 5 | 2026-05-08 |
| INVA | Innoviva, Inc. Common Stock | 90 | ±0 | Leader | to profit↓ | +11% | -1120 bps | 64 | 2026-05-06 |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | 90 | ±0 | Leader | — | — | — | 55 | new filing |
| PAHC | Phibro Animal Health Corporation Class A | 90 | ±0 | Leader | +16% | +10%↓ | +400 bps | 34 | 2026-05-06 |
| FBIO | Fortress Biotech, Inc. | 89 | ±0 | Strong | to profit | +21% | +8710 bps | 48 | 2026-05-14 |
| GEVO | Gevo, Inc. | 89 | ±0 | Strong | loss widened 0%↓ | +48%↓ | >+10,000 bps | 37 | 2026-05-07 |
| GPRE | Green Plains, Inc. | 89 | ±0 | Strong | to profit↑ | +19% | +6154 bps | 90 | 2026-05-07 |
| HYPR | Hyperfine, Inc. Class A Common Stock | 89 | ±0 | Strong | loss narrowed 25% | +83% | >+10,000 bps | 32 | 2026-05-12 |
| NVST | Envista Holdings Corporation Common stock, $0.01 par value per share | 89 | ±0 | Leader | +130% | +14% | +5036 bps | 64 | 2026-05-06 |
| PACS | PACS Group, Inc. | 89 | ±0 | Strong | +194% | +11%↓ | +464 bps | 71 | 2026-05-11 |
| PPG | PPG Industries, Inc. | 89 | ±0 | Leader | +4% | +7% | +138 bps | 61 | 2026-04-29 |
| PRVA | Privia Health Group, Inc. Common Stock | 89 | +1 | Strong | -33% | +26% | +44 bps | 67 | 2026-05-07 |
| QUCY | Quantum Cyber N.V. Ordinary Shares | 89 | ±0 | Strong | loss narrowed 71% | +141%↑ | — | — | 2026-05-15 |
| ADCT | ADC Therapeutics SA | 88 | ±0 | Strong | loss narrowed 42% | +15% | +3746 bps | 7 | 2026-05-04 |
| COLL | Collegium Pharmaceutical, Inc. Common Stock | 88 | ±0 | Strong | +471% | +9%↓ | +232 bps | 28 | 2026-05-07 |
| PHAR | Pharming Group N.V. ADS, each representing 10 ordinary shares | 88 | ±0 | Strong | to profit | +27% | +977 bps | 25 | 2026-04-02 |
| PNTG | The Pennant Group, Inc. Common Stock | 88 | ±0 | Strong | +9% | +36% | -12 bps | 87 | 2026-05-06 |
| PRME | Prime Medicine, Inc. Common Stock | 88 | ±0 | Strong | loss narrowed 30%↑ | -62%↓ | — | 29 | 2026-05-07 |
| RNXT | RenovoRx, Inc. Common Stock | 88 | ±0 | Strong | loss narrowed 20% | >+999% | — | 35 | 2026-05-14 |
| URGN | UroGen Pharma Ltd. Ordinary SharesBiotech & Genomics | 88 | ±0 | Strong33 | loss narrowed 49%↑ | +152%↑ | +4049 bps | 97 | 2026-05-06 |
| ASND | Ascendis Pharma A/S Ordinary Share | 87 | ±0 | Strong | loss narrowed 10%↓ | +42%↓ | +5774 bps | 74 | 2026-02-11 |
| BCYC | Bicycle Therapeutics plc American Depositary Shares | 87 | ±0 | Strong | loss narrowed 1% | -91% | >+10,000 bps | 20 | 2026-04-30 |
| ESTA | Establishment Labs Holdings Inc. | 87 | ±0 | Strong | loss narrowed 36% | +45% | +2168 bps | 89 | 2026-05-08 |
| FTLF | FitLife Brands, Inc. Common Stock | 87 | ±0 | Strong | -15% | +59% | -869 bps | 24 | 2026-05-14 |
| SNTI | Senti Biosciences Holdings, Inc. Common Stock | 87 | +1 | Strong | loss narrowed 90% | — | — | 9 | 2026-05-14 |
| STIM | Neuronetics, Inc. Common Stock | 87 | ±0 | Strong | loss narrowed 24% | +8%↓ | +2389 bps | 69 | 2026-05-05 |
| YSG | Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | 87 | ±0 | Strong | loss narrowed 80% | +32% | +1999 bps | 33 | 2026-04-29 |
| ABBV | ABBVIE INC. | 86 | ±0 | Strong | -46% | +12%↑ | — | 74 | 2026-05-08 |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | 86 | ±0 | Strong | loss narrowed 35%↓ | +35%↓ | +5984 bps | 79 | 2026-05-05 |
| ALT | Altimmune, Inc. Common StockGLP-1 / Obesity | 86 | ±0 | Strong | loss narrowed 31% | +420% | — | 21 | 2026-05-13 |
| IMCR | Immunocore Holdings plc American Depositary Shares | 86 | ±0 | Strong | +150%↑ | +14%↓ | +592 bps | 60 | 2026-05-06 |
| IVVD | Invivyd, Inc. Common Stock | 86 | ±0 | Strong | loss narrowed 7% | +22%↓ | >+10,000 bps | 6 | 2026-05-14 |
| KRYS | Krystal Biotech, Inc. Common Stock | 86 | ±0 | Strong | +53% | +32%↑ | +1029 bps | 77 | 2026-05-04 |
| LUCY | Innovative Eyewear, Inc. Common Stock | 86 | ±0 | Strong | loss narrowed 49% | +70% | — | 11 | 2026-05-14 |
| NSPR | InspireMD, Inc. | 86 | ±0 | Strong | loss narrowed 27% | +122%↑ | — | 9 | 2026-05-07 |
| SNDX | Syndax Pharmaceuticals, Inc. | 86 | ±0 | Strong | loss narrowed 51% | +224% | >+10,000 bps | 64 | 2026-04-30 |
| ADMA | ADMA Biologics, Inc. | 85 | ±0 | Strong | +73% | 0% | +904 bps | 12 | 2026-05-06 |
| APYX | Apyx Medical Corporation Common Stock | 85 | ±0 | Strong | loss narrowed 50% | +32% | +2461 bps | 61 | 2026-05-07 |
| ATRC | AtriCure, Inc. | 85 | ±0 | Strong | to profit | +14% | +676 bps | 35 | 2026-05-06 |
| DARE | Dare Bioscience, Inc. Common Stock | 85 | ±0 | Strong | loss narrowed 58% | +500% | — | 23 | 2026-05-14 |
| LNTH | Lantheus Holdings, Inc | 85 | ±0 | Strong | +76% | +1% | -1068 bps | 93 | 2026-05-07 |
| MOV | Movado Group, Inc. | 85 | ±0 | Strong | +400% | +8% | +257 bps | 95 | 2026-05-27 |
| MREO | Mereo BioPharma Group plc American Depositary Shares | 85 | +1 | Strong | loss narrowed 50% | — | — | 10 | 2026-05-12 |
| NRXP | NRX Pharmaceuticals, Inc. Common Stock | 85 | ±0 | Strong | loss narrowed 88% | — | — | 96 | 2026-05-15 |
| NRXS | Neuraxis, Inc. | 85 | ±0 | Strong | loss narrowed 45%↑ | +80%↑ | — | 91 | 2026-05-12 |
| STTK | Shattuck Labs, Inc. Common Stock | 85 | ±0 | Strong | loss narrowed 52% | — | — | 92 | 2026-05-07 |
| TCRX | TScan Therapeutics, Inc. Common Stock | 85 | ±0 | Strong | loss narrowed 15% | -55% | — | 32 | 2026-05-06 |
| VCEL | Vericel Corporation | 85 | ±0 | Strong | loss narrowed 48% | +30%↑ | +658 bps | 76 | 2026-05-07 |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | 84 | ±0 | Strong | +375%↑ | +4%↓ | +156 bps | 85 | 2026-05-07 |
| AXSM | Axsome Therapeutics, Inc | 84 | -1 | Strong | loss widened 3% | +57% | +3809 bps | 82 | 2026-05-04 |
| DXCM | DexCom, Inc. | 84 | ±0 | Strong | +89% | +15% | +620 bps | 66 | 2026-04-30 |
| ENSC | Ensysce Biosciences, Inc. Common Stock | 84 | ±0 | Strong | loss narrowed 63% | -27% | — | 6 | 2026-05-15 |
| EYE | National Vision Holdings, Inc. Common Stock | 84 | ±0 | Strong | +111% | +7% | +427 bps | 22 | 2026-05-14 |
| IOVA | Iovance Biotherapeutics, Inc. Common Stock | 84 | ±0 | Strong33 | loss narrowed 47%↑ | +45%↑ | +6034 bps | 97 | 2026-05-07 |
| JAZZ | Jazz Pharmaceuticals, Inc. | 84 | ±0 | Strong | to profit | +19%↑ | -1548 bps | 89 | 2026-05-05 |
| PRLD | Prelude Therapeutics Incorporated | 84 | ±0 | Strong | loss narrowed 23% | +73% | — | 96 | 2026-05-12 |
| BHST | BioHarvest Sciences Inc. Common Stock | 83 | ±0 | Strong | loss narrowed 25% | +37% | +1159 bps | 13 | 2026-03-31 |
| BSX | Boston Scientific Corp. | 83 | ±0 | Strong | +100% | +12%↓ | +217 bps | 11 | 2026-05-01 |
| COCP | Cocrystal Pharma, Inc. Common Stock | 83 | ±0 | Strong | loss narrowed 26%↓ | — | — | 35 | 2026-05-15 |
| ELMD | Electromed, Inc. | 83 | ±0 | Strong | +67% | +18%↑ | +368 bps | 90 | 2026-05-12 |
| EOLS | Evolus, Inc. Common Stock | 83 | ±0 | Strong | loss narrowed 47% | +7% | +670 bps | 68 | 2026-05-04 |
| GERN | Geron Corp | 83 | ±0 | Strong | loss narrowed 67% | +31%↓ | — | 68 | 2026-05-06 |
| NATR | Nature's Sunshine Products Inc. | 83 | ±0 | Strong | +16% | +9% | +100 bps | 45 | 2026-05-07 |
| NXL | Nexalin Technology, Inc. Common Stock | 83 | -1 | Strong | loss narrowed 27% | -64% | — | 24 | 2026-05-08 |
| ODD | ODDITY Tech Ltd. Class A Ordinary Shares | 83 | -1 | Strong | +10% | +25% | -320 bps | 10 | 2026-03-17 |
| ORGO | Organogenesis Holdings Inc. Class A Common Stock | 83 | ±0 | Strong | loss widened 159% | -57% | +577 bps | 21 | 2026-05-07 |
| PHIO | Phio Pharmaceuticals Corp. Common Stock | 83 | ±0 | Strong | loss narrowed 17% | — | — | 48 | 2026-05-07 |
| PMI | Picard Medical, Inc. | 83 | ±0 | Strong | loss narrowed 75% | +13% | — | 2 | 2026-05-15 |
| TOI | The Oncology Institute, Inc. Common Stock | 83 | ±0 | Strong | loss narrowed 90%↑ | +41% | +692 bps | 94 | 2026-05-07 |
| WLKP | WESTLAKE CHEMICAL PARTNERS LP | 83 | ±0 | Strong | +93%↑ | +29% | -229 bps | 61 | 2026-05-06 |
| COCH | Envoy Medical, Inc. Class A Common Stock | 82 | ±0 | Strong | loss narrowed 72%↑ | -15% | — | 53 | 2026-05-11 |
| HXL | Hexcel Corporation | 82 | ±0 | Strong | +40% | +10%↑ | +14 bps | 81 | 2026-04-22 |
| NVMI | Nova Ltd. Ordinary Shares | 82 | ±0 | Strong | +38% | +31% | +89 bps | 53 | 2026-02-17 |
| VIVS | VivoSim Labs, Inc. Common Stock | 82 | +3 | Strong | to profit | +121%↑ | — | 5 | new filing |
| ARWR | Arrowhead Research CorporationGLP-1 / Obesity | 81 | ±0 | Strong | to loss | -86%↓ | -1393 bps | 65 | 2026-05-07 |
| BBIO | BridgeBio Pharma, Inc. Common Stock | 81 | ±0 | Strong | loss narrowed 5% | +67%↓ | >+10,000 bps | 62 | 2026-05-07 |
| CCM | Concord Medical Services Holding Limited | 81 | ±0 | Strong | loss narrowed 70% | +21% | +8451 bps | 45 | 2026-04-29 |
| DYAI | Dyadic International, Inc. | 81 | -1 | Strong | loss narrowed 29%↑ | +182%↑ | — | 87 | 2026-05-13 |
| OCS | Oculis Holding AG Ordinary shares | 81 | ±0 | Strong | loss narrowed 11% | +75% | — | 11 | 2026-03-04 |
| SNOA | Sonoma Pharmaceuticals, Inc. Common Stock | 81 | ±0 | Strong | loss narrowed 78% | +48% | +1336 bps | 7 | 2026-06-16 |
| TCMD | Tactile Systems Technology, Inc. | 81 | ±0 | Strong | loss narrowed 38% | +23%↑ | +237 bps | 45 | 2026-05-04 |
| BCDA | BioCardia, Inc. Common Stock | 80 | ±0 | Strong | loss narrowed 64% | — | — | 20 | 2026-05-15 |
| BVS | Bioventus Inc. Class A Common Stock | 80 | ±0 | Strong | to profit | +7%↑ | +1217 bps | 90 | 2026-05-06 |
| NHC | National Healthcare Corp. | 80 | ±0 | Strong | +10% | +2%↓ | +119 bps | 93 | 2026-05-07 |
| PLRX | Pliant Therapeutics, Inc. Common Stock | 80 | ±0 | Strong | loss narrowed 65%↑ | — | — | 35 | 2026-05-11 |
| SIBN | SI-BONE, Inc. Common Stock | 80 | ±0 | Strong | loss narrowed 33% | +11%↓ | +770 bps | 50 | 2026-05-11 |
| VMD | Viemed Healthcare, Inc. Common Shares | 80 | ±0 | Strong | 0% | +28%↑ | -23 bps | 93 | 2026-05-05 |
| ATEC | Alphatec Holdings, Inc. | 79 | ±0 | Strong | loss narrowed 37% | +14%↓ | +1367 bps | 11 | 2026-05-05 |
| BFLY | Butterfly Network, Inc. | 79 | ±0 | Strong | loss narrowed 17% | +25% | +255 bps | 90 | 2026-04-30 |
| CBIO | Crescent Biopharma, Inc. Common Stock | 79 | ±0 | Strong | loss narrowed 76%↑ | — | — | 77 | 2026-04-29 |
| CERS | Cerus Corp | 79 | +1 | Strong | loss narrowed 75% | +24% | — | 72 | 2026-04-30 |
| HYFT | MindWalk Holdings Corp. Common Stock | 79 | ±0 | Strong | loss narrowed 88%↑ | -32% | — | 25 | 2026-03-12 |
| INFU | InfuSystem Holdings, Inc. | 79 | ±0 | Strong | to profit↑ | -3% | +298 bps | 59 | 2026-05-08 |
| LMAT | LeMaitre Vascular, Inc. | 79 | ±0 | Strong | +42%↓ | +11% | +508 bps | 75 | 2026-05-06 |
| NTLA | Intellia Therapeutics, IncBiotech & Genomics | 79 | ±0 | Strong | loss narrowed 26% | -9% | >+10,000 bps | 44 | 2026-05-11 |
| SHC | Sotera Health Company Common Stock | 79 | ±0 | Strong | to profit | +10% | +928 bps | 42 | 2026-05-05 |
| SSII | SS Innovations International Inc. Common Stock | 79 | ±0 | Strong | loss narrowed 33% | +117% | +5587 bps | 22 | 2026-05-13 |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | 79 | ±0 | Strong | +72% | +2% | +1059 bps | 48 | 2026-04-29 |
| CLLS | Cellectis S.A. American Depositary Shares | 78 | ±0 | Strong | loss narrowed 14% | +107% | — | 19 | 2026-03-20 |
| CON | Concentra Group Holdings Parent, Inc. | 78 | ±0 | Strong | +30% | +14%↓ | -37 bps | 90 | 2026-05-07 |
| CRBU | Caribou Biosciences, Inc. Common Stock | 78 | ±0 | Strong | loss narrowed 40%↑ | +2% | — | 59 | 2026-05-07 |
| FTK | Flotek Industries, Inc. | 78 | ±0 | Strong | -29% | +27% | +228 bps | 93 | 2026-05-07 |
| INM | InMed Pharmaceuticals Inc. Common Shares | 78 | ±0 | Strong | loss narrowed 86% | -26%↓ | — | 89 | 2026-05-06 |
| RFL | Rafael Holdings, Inc. Class B Common Stock | 78 | ±0 | Strong | loss narrowed 58% | -51% | — | 95 | 2026-06-11 |
| ADUS | Addus HomeCare Corp. | 77 | ±0 | Strong | +17% | +8% | +77 bps | 56 | 2026-05-05 |
| INMB | INmune Bio Inc. Common stock | 77 | ±0 | Strong | loss narrowed 53% | — | — | 79 | 2026-05-07 |
| KEYS | Keysight Technologies, Inc. | 77 | ±0 | Strong | +36%↓ | +31%↑ | +133 bps | 90 | 2026-06-04 |
| MGNX | MacroGenics, Inc. | 77 | ±0 | Strong | loss narrowed 11%↑ | +57% | +2403 bps | 98 | 2026-05-13 |
| NPCE | Neuropace, Inc. Common Stock | 77 | ±0 | Strong | loss narrowed 5% | -2%↓ | +602 bps | 42 | 2026-05-12 |
| NUVB | Nuvation Bio Inc. | 77 | ±0 | Strong | to profit | >+999% | >+10,000 bps | 57 | 2026-05-04 |
| VTGN | Vistagen Therapeutics, Inc. Common Stock | 77 | ±0 | Strong | loss narrowed 16%↑ | — | — | 7 | 2026-06-15 |
| AVIR | Atea Pharmaceuticals, Inc. Common Stock | 76 | ±0 | Strong | loss narrowed 3% | +622% | — | 88 | 2026-05-12 |
| EXEL | Exelixis IncBiotech & Genomics | 76 | ±0 | Strong | +44% | +10% | +628 bps | 79 | 2026-05-05 |
| HOWL | Werewolf Therapeutics, Inc. Common Stock | 76 | +1 | Strong | loss narrowed 30% | — | — | 21 | 2026-05-07 |
| IMAX | Imax Corp | 76 | ±0 | Strong | +75% | -6% | +564 bps | 63 | 2026-04-30 |
| INTT | inTEST Corporation | 76 | ±0 | Strong33 | to profit↑ | +27%↑ | +132 bps | 92 | 2026-05-11 |
| ISRG | Intuitive Surgical Inc.Robotics & Automation | 76 | ±0 | Strong | +19% | +23% | +225 bps | 20 | 2026-04-22 |
| ITGR | Integer Holdings Corporation | 76 | +1 | Strong | to profit↑ | +1% | -159 bps | 70 | 2026-04-30 |
| MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | 76 | ±0 | Strong | loss narrowed 2%↑ | +127%↓ | >+10,000 bps | 64 | 2026-05-06 |
| MRKR | Marker Therapeutics, Inc. Common Stock | 76 | ±0 | Strong | loss narrowed 60% | +115% | — | 26 | 2026-05-15 |
| QGEN | QIAGEN N.V. | 76 | ±0 | Strong | +424% | +6% | +1735 bps | 35 | 2026-03-20 |
| SNES | SenesTech, Inc. Common Stock | 76 | ±0 | Strong | loss narrowed 70% | +2% | — | 21 | 2026-05-13 |
| XFOR | X4 Pharmaceuticals, Inc. Common Stock | 76 | ±0 | Strong | to loss | -91%↓ | — | 56 | 2026-05-06 |
| ABCL | AbCellera Biologics Inc. Common SharesBiotech & Genomics | 75 | ±0 | Strong | loss narrowed 7% | +96% | >+10,000 bps | 88 | 2026-05-11 |
| ALLO | Allogene Therapeutics, Inc. Common Stock | 75 | ±0 | Strong | loss narrowed 36%↓ | — | — | 67 | 2026-05-13 |
| ALNT | Allient Inc. Common Stock | 75 | ±0 | Strong | +52%↓ | +5% | +277 bps | 88 | 2026-05-06 |
| BMY | Bristol-Myers Squibb Co. | 75 | ±0 | Strong | +9% | +3% | +697 bps | 62 | 2026-04-30 |
| COYA | Coya Therapeutics, Inc. Common Stock | 75 | ±0 | Strong | loss narrowed 27% | -3%↓ | — | 67 | 2026-05-12 |
| CRON | Cronos Group Inc. Common Share | 75 | ±0 | Strong | +100% | +40% | +4239 bps | 65 | 2026-05-11 |
| INSM | Insmed, Inc.Biotech & Genomics | 75 | ±0 | Strong33 | loss narrowed 46%↑ | +230%↑ | >+10,000 bps | 22 | 2026-05-07 |
| VRDN | Viridian Therapeutics, Inc. Common Stock | 75 | ±0 | Strong | loss widened 35%↓ | +96% | — | 15 | 2026-05-05 |
| CDNA | CareDx, Inc. | 74 | ±0 | Strong | to profit | +39%↑ | -1742 bps | 96 | 2026-04-28 |
| ENSG | The Ensign Group, Inc. | 74 | ±0 | Strong | +22%↑ | +18%↓ | +3 bps | 46 | 2026-04-30 |
| IRWD | Ironwood Pharmaceuticals, Inc. - Class A | 74 | ±0 | Strong | to profit | +159% | +3869 bps | 37 | 2026-05-07 |
| ITRI | Itron Inc | 74 | ±0 | Strong | -17% | -3% | +162 bps | 35 | 2026-04-28 |
| PDEX | Pro-Dex Inc New | 74 | ±0 | Strong | +22% | +15% | -376 bps | 85 | 2026-04-30 |
| PROF | Profound Medical Corp. Common Stock | 74 | ±0 | Strong | -47% | +128% | >+10,000 bps | 33 | 2026-05-07 |
| RYTM | Rhythm Pharmaceuticals, Inc. Common StockBiotech & Genomics | 74 | ±0 | Strong | loss widened 2%↑ | +84% | +3524 bps | 51 | 2026-05-05 |
| TALK | Talkspace, Inc. Common Stock | 74 | -1 | Strong | to loss | +18% | +252 bps | 87 | 2026-05-11 |
| ACIU | AC Immune SA | 73 | +1 | Strong | loss narrowed 9% | +90% | — | 18 | 2026-03-13 |
| CGNX | Cognex CorpRobotics & Automation | 73 | ±0 | Strong | +121%↑ | +24% | +495 bps | 92 | 2026-05-07 |
| ECOR | electroCore, Inc. Common Stock | 73 | ±0 | Strong | loss widened 26% | +43% | +389 bps | 41 | 2026-05-06 |
| IRMD | iRadimed Corporation | 73 | ±0 | Strong | +22% | +13% | +226 bps | 47 | 2026-05-01 |
| IXHL | Incannex Healthcare Limited American Depositary Shares | 73 | ±0 | Strong | loss widened 17% | +617% | — | 6 | 2026-05-15 |
| KTTA | Pasithea Therapeutics Corp. Common Stock | 73 | ±0 | Strong | loss narrowed 77% | >+999% | — | 13 | 2026-05-15 |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | 73 | ±0 | Strong | loss narrowed 35%↑ | — | — | 16 | 2026-05-13 |
| OBIO | Orchestra BioMed Holdings, Inc. Ordinary Shares | 73 | ±0 | Strong | loss narrowed 33% | -87% | — | 40 | 2026-05-12 |
| QURE | uniQure N.V.Biotech & Genomics | 73 | ±0 | Strong | loss widened 4% | +127% | <-10,000 bps | 96 | 2026-05-05 |
| RGEN | Repligen Corp | 73 | ±0 | Strong | +50%↓ | +15%↓ | +1342 bps | 42 | 2026-05-06 |
| RNTX | Rein Therapeutics, Inc. Common Stock | 73 | ±0 | Strong | loss narrowed 24% | — | — | 26 | 2026-05-15 |
| ROG | Rogers Corporation | 73 | ±0 | Strong | to profit | +5%↑ | -574 bps | 84 | 2026-04-29 |
| RPRX | Royalty Pharma plc Class A Ordinary Shares | 73 | ±0 | Strong | +22%↑ | +11% | -1886 bps | 90 | 2026-05-06 |
| SNDL | Sundial Growers Inc. Common Shares | 73 | ±0 | Strong | loss narrowed 83% | +3% | +1001 bps | 30 | 2026-03-12 |
| AQST | Aquestive Therapeutics, Inc. Common Stock | 72 | ±0 | Strong | loss narrowed 71% | +66%↑ | -3524 bps | 75 | 2026-05-13 |
| AZN | AstraZeneca PLC | 72 | ±0 | Strong | +27% | +12% | — | 95 | 2026-02-24 |
| GRMN | Garmin Ltd | 72 | ±0 | Strong | +22%↑ | +14% | +121 bps | 72 | 2026-04-29 |
| HCSG | Healthcare Services Group | 72 | ±0 | Strong | +61%↓ | +3%↓ | +105 bps | 84 | 2026-04-24 |
| NEGG | Newegg Commerce, Inc. Common Shares | 72 | ±0 | Strong | loss narrowed 89% | +17% | +351 bps | 5 | 2026-04-28 |
| PACB | Pacific Biosciences of California, Inc. | 72 | ±0 | Strong | loss narrowed 98%↑ | 0% | >+10,000 bps | 16 | 2026-05-08 |
| SLS | SELLAS Life Sciences Group, Inc. Common Stock | 72 | +1 | Strong | loss narrowed 29% | — | — | 99 | 2026-05-12 |
| AMGN | Amgen IncGLP-1 / Obesity | 71 | ±0 | Strong | +4% | +6%↓ | +658 bps | 67 | 2026-05-01 |
| IFRX | InflaRx N.V. Common Stock | 71 | ±0 | Strong | loss narrowed 13%↑ | +520% | — | 96 | 2026-03-20 |
| LNSR | LENSAR, Inc. Common Stock | 71 | +1 | Strong | to profit↑ | -4%↓ | -494 bps | 11 | 2026-05-08 |
| PRQR | ProQR Therapeutics N.V. Ordinary Shares | 71 | ±0 | Strong | loss narrowed 20%↑ | +9%↑ | <-10,000 bps | 69 | 2026-03-12 |
| SEPN | Septerna, Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 61% | >+999% | — | 75 | 2026-05-11 |
| SPAI | Safe Pro Group Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 48% | +560% | — | 17 | 2026-05-15 |
| ST | Sensata Technologies Holding plc | 71 | ±0 | Strong | +26% | +3%↑ | +359 bps | 82 | 2026-04-28 |
| VIR | Vir Biotechnology, Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 3% | -101% | >+10,000 bps | 91 | 2026-05-07 |
| XBIO | Xenetic Biosciences, Inc. | 71 | ±0 | Strong | loss narrowed 66% | +36% | — | 80 | 2026-05-12 |
| AXIL | AXIL Brands, Inc. | 70 | ±0 | Strong | -71%↓ | +5%↑ | — | 24 | 2026-04-08 |
| BLFS | BioLife Solutions Inc. | 70 | ±0 | Strong | to profit | +15% | — | 76 | 2026-05-07 |
| CODA | Coda Octopus Group, Inc. Common stock | 70 | ±0 | Strong | +88% | -2%↓ | +494 bps | 39 | 2026-06-15 |
| FHTX | Foghorn Therapeutics Inc. Common Stock | 70 | ±0 | Strong | loss narrowed 3% | -45% | >+10,000 bps | 34 | 2026-05-07 |
| GH | Guardant Health, Inc. Common StockBiotech & Genomics | 70 | ±0 | Strong | loss widened 10% | +48%↑ | +1735 bps | 85 | 2026-05-07 |
| MMSI | Merit Medical Systems Inc | 70 | ±0 | Strong | +39% | +7%↓ | +60 bps | 46 | 2026-04-30 |
| RCKT | Rocket Pharmaceuticals, Inc. Common Stock | 70 | ±0 | Strong | loss narrowed 25% | — | — | 44 | 2026-05-07 |
| ROP | Roper Technologies, Inc. Common Stock | 70 | ±0 | Strong | +59% | +11% | -10 bps | 39 | 2026-05-01 |
| TELA | TELA Bio, Inc. Common Stock | 70 | +1 | Strong | loss narrowed 16% | +3% | +1400 bps | 26 | 2026-05-13 |
| UHS | Universal Health Services, Inc. Class B | 70 | ±0 | Strong | +18%↓ | +10% | +63 bps | 27 | 2026-05-07 |
| BTAI | BioXcel Therapeutics, Inc. Common Stock | 69 | ±0 | Average | loss narrowed 64% | +23%↑ | — | 10 | 2026-05-15 |
| CYTK | Cytokinetics Inc. | 69 | ±0 | Strong | loss widened 23% | >+999% | >+10,000 bps | 81 | 2026-05-05 |
| NDRA | ENDRA Life Sciences Inc. Common Stock | 69 | ±0 | Average | loss narrowed 41%↓ | — | — | 68 | 2026-05-15 |
| OFIX | Orthofix Medical Inc. Common Stock (DE) | 69 | ±0 | Strong | loss narrowed 61% | +2%↓ | +725 bps | 32 | 2026-05-05 |
| PYXS | Pyxis Oncology, Inc. Common Stock | 69 | ±0 | Average | loss widened 6% | — | — | 79 | 2026-05-14 |
| SNN | Smith & Nephew plc | 69 | ±0 | Average | +52% | +6% | +157 bps | 44 | 2026-03-16 |
| THC | Tenet Healthcare Corporation New | 69 | +1 | Average | +88%↑ | +3% | +38 bps | 49 | 2026-04-30 |
| VRTX | Vertex Pharmaceuticals IncBiotech & Genomics | 69 | ±0 | Strong | +61%↑ | +8%↓ | +4500 bps | 66 | 2026-05-05 |
| CF | CF Industries Holding, Inc. | 68 | ±0 | Average | +115% | +19% | +559 bps | 89 | 2026-05-07 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 68 | ±0 | Average | loss widened 18% | >+999% | — | 91 | 2026-05-07 |
| EHC | Encompass Health Corporation Common Stock | 68 | ±0 | Average | +30%↑ | +9% | +78 bps | 66 | 2026-05-01 |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | 68 | ±0 | Average | +123% | +4% | +1147 bps | 57 | 2026-07-10 |
| HCM | HUTCHMED (China) Limited American Depositary Shares | 68 | ±0 | Average | >+999% | -13% | -20 bps | 27 | 2026-03-05 |
| STE | STERIS plc | 68 | ±0 | Average | +51% | +7%↓ | +269 bps | 32 | 2026-05-29 |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 68 | -1 | Average | loss widened 3% | +183%↑ | >+10,000 bps | 23 | 2026-05-11 |
| TSHA | Taysha Gene Therapies, Inc. Common Stock | 68 | ±0 | Average | loss widened 50%↓ | -100% | — | 71 | 2026-05-06 |
| TWST | Twist Bioscience Corporation Common StockBiotech & Genomics | 68 | ±0 | Average | loss widened 8%↓ | +19%↑ | +2396 bps | 97 | 2026-05-04 |
| CYPH | Cypherpunk Technologies Inc. Common Stock | 67 | ±0 | Average | loss widened 24% | 0% | — | 20 | 2026-05-14 |
| GOSS | Gossamer Bio, Inc. Common Stock | 67 | ±0 | Average | loss widened 25% | +71%↑ | <-10,000 bps | 2 | 2026-05-15 |
| IDXX | Idexx Laboratories Inc | 67 | ±0 | Average | +17%↓ | +14% | +248 bps | 31 | 2026-05-05 |
| NAGE | Niagen Bioscience, Inc. Common Stock | 67 | ±0 | Average | +17% | +3%↓ | -223 bps | 13 | 2026-05-06 |
| NUWE | Nuwellis, Inc. Common Stock | 67 | ±0 | Average | loss widened 217% | +26%↑ | — | 2 | 2026-05-15 |
| PHG | KONINKLIJKE PHILIPS N.V. | 67 | ±0 | Average | to profit | -1% | +516 bps | 44 | 2026-02-19 |
| RLAY | Relay Therapeutics, Inc. Common Stock | 67 | ±0 | Average | loss narrowed 11%↓ | -61% | — | 98 | 2026-05-05 |
| ROK | Rockwell Automation, Inc.Robotics & Automation | 67 | ±0 | Average | +40% | +12%↓ | +1142 bps | 65 | 2026-05-05 |
| SCNX | Scienture Holdings, Inc. Common Stock | 67 | ±0 | Average | loss narrowed 76%↓ | +449% | — | 31 | 2026-05-15 |
| SDGR | Schrodinger, Inc. Common Stock | 67 | ±0 | Average | loss narrowed 1% | -2%↓ | +1897 bps | 37 | 2026-05-05 |
| SYK | Stryker Corporation | 67 | +1 | Average | +14% | +3% | +443 bps | 40 | 2026-05-11 |
| XGN | Exagen Inc. Common Stock | 67 | ±0 | Average | loss narrowed 15%↑ | +12%↓ | +403 bps | 49 | 2026-05-11 |
| ZLAB | Zai Lab Limited American Depositary Shares | 67 | ±0 | Average | loss widened 25% | -10% | +1019 bps | 66 | 2026-05-07 |
| AGIO | Agios Pharmaceuticals, Inc. | 66 | ±0 | Average33 | loss widened 9%↑ | +138%↑ | >+10,000 bps | 90 | 2026-04-29 |
| ATYR | aTyr Pharma, Inc. Common Stock | 66 | ±0 | Average | loss narrowed 35%↑ | — | — | 23 | 2026-05-15 |
| BTMD | Biote Corp. Class A Common Stock | 66 | +1 | Average | -84% | -8%↓ | -6 bps | 60 | 2026-05-11 |
| CGON | CG Oncology, Inc. Common stock | 66 | ±0 | Average | loss widened 58% | >+999% | — | 85 | 2026-05-08 |
| ENOV | Enovis Corporation | 66 | ±0 | Average | loss narrowed 85%↑ | +5% | -1038 bps | 68 | 2026-05-07 |
| PEN | Penumbra, Inc. | 66 | ±0 | Average | -18%↓ | +16% | — | 42 | 2026-05-06 |
| VYGR | Voyager Therapeutics, Inc. Common Stock | 66 | +1 | Average | loss narrowed 11% | -60% | <-10,000 bps | 31 | 2026-05-07 |
| CV | CapsoVision, Inc. Common Stock | 65 | ±0 | Average | loss narrowed 94% | 0% | — | 69 | 2026-05-14 |
| ENTA | Enanta Pharmaceuticals, Inc | 65 | ±0 | Average | loss narrowed 58% | +15% | +8353 bps | 51 | 2026-05-13 |
| LUNR | Intuitive Machines, Inc. Class A Common StockSpace Economy | 65 | -1 | Average | loss widened 127%↓ | +194% | — | 24 | 2026-05-15 |
| NL | NLI Holdings, Inc. | 65 | ±0 | Average | +800% | +1% | -1942 bps | 43 | 2026-05-06 |
| NXGL | NexGel, Inc Common Stock | 65 | ±0 | Average | loss widened 22%↓ | -6% | +247 bps | 5 | 2026-05-14 |
| RMD | ResMed Inc. | 65 | ±0 | Average | +10% | +11% | +207 bps | 28 | 2026-05-01 |
| SGHT | Sight Sciences, Inc. Common Stock | 65 | ±0 | Average | loss narrowed 14% | +13%↑ | +1877 bps | 29 | 2026-05-06 |
| GDTC | CytoMed Therapeutics Limited Ordinary Shares | 64 | ±0 | Average | loss widened 69% | +367% | — | 60 | 2026-03-31 |
| HROW | Harrow, Inc. Common Stock | 64 | ±0 | Average | loss widened 48%↓ | -8%↓ | +520 bps | 44 | 2026-05-11 |
| KLAC | KLA Corporation Common StockSemiconductors | 64 | ±0 | Average | +12% | +11% | +423 bps | 86 | 2026-04-30 |
| NNVC | NanoViricides Inc. | 64 | ±0 | Average | loss narrowed 36% | — | — | 92 | 2026-05-15 |
| NTR | Nutrien Ltd. Common Shares | 64 | ±0 | Average | +243% | +4% | +675 bps | 51 | 2026-02-27 |
| PRPO | Precipio, Inc. Common Stock | 64 | ±0 | Average | loss widened 37% | +42% | +761 bps | 50 | 2026-05-14 |
| VANI | Vivani Medical, Inc. Common Stock (DE) | 64 | ±0 | Average | loss narrowed 27%↑ | — | — | 63 | 2026-05-13 |
| AVNT | Avient Corporation | 63 | ±0 | Average | to profit | +3%↑ | +181 bps | 54 | 2026-05-07 |
| FMS | Fresenius Medical Care AG | 63 | ±0 | Average | +414%↑ | -4% | +260 bps | 69 | 2026-02-24 |
| MRNA | Moderna, Inc. Common StockBiotech & Genomics | 63 | ±0 | Average | loss widened 35% | +260%↑ | -3597 bps | 92 | 2026-05-01 |
| PGNY | Progyny, Inc. Common Stock | 63 | ±0 | Average | +71% | +1%↓ | +144 bps | 85 | 2026-05-08 |
| WRBY | Warby Parker Inc. | 63 | ±0 | Average | 0%↓ | +8%↓ | +214 bps | 38 | 2026-05-07 |
| CVRX | CVRx, Inc. Common Stock | 62 | ±0 | Average | loss narrowed 6% | +20% | +1126 bps | 39 | 2026-05-12 |
| ICU | SeaStar Medical Holding Corporation Common Stock | 62 | ±0 | Average | loss widened 105%↓ | +69% | — | 91 | 2026-05-13 |
| LTBR | Lightbridge Corp. | 62 | ±0 | Average | loss narrowed 17%↑ | — | — | 9 | 2026-04-30 |
| MKSI | MKS Inc. Common Stock | 62 | ±0 | Average | +53% | +15%↑ | +13 bps | 93 | 2026-05-07 |
| NOC | Northrop Grumman Corp.Defense / Drones | 62 | +1 | Average | +85%↑ | +4% | +204 bps | 32 | 2026-04-21 |
| SBFM | Sunshine Biopharma Inc. | 62 | ±0 | Average | loss narrowed 43% | -9% | -194 bps | 3 | 2026-05-13 |
| STAA | Staar Surgical Co | 62 | ±0 | Average33 | to profit↑ | +120%↑ | +1520 bps | 72 | 2026-05-13 |
| WVE | Wave Life Sciences Ltd. Ordinary Shares | 62 | ±0 | Average | loss narrowed 55% | +317% | — | 9 | 2026-04-28 |
| ABVC | ABVC BioPharma, Inc. Common Stock | 61 | ±0 | Average | loss widened 0%↑ | >+999%↑ | — | 17 | 2026-05-18 |
| ACAD | Acadia Pharmaceuticals Inc. | 61 | ±0 | Average | -82%↓ | +10% | -1619 bps | 47 | 2026-05-07 |
| CE | Celanese Corporation Common Stock | 61 | ±0 | Average | to profit↑ | -2%↑ | -45 bps | 47 | 2026-05-06 |
| DCTH | Delcath Systems Inc | 61 | ±0 | Average | to loss | +26%↓ | +98 bps | 80 | 2026-05-07 |
| DRIO | DarioHealth Corp. Common Stock | 61 | -1 | Average | +793% | -17%↑ | +1279 bps | 15 | 2026-05-13 |
| MTEX | Mannatech Inc. | 61 | ±0 | Average | to profit | -6%↑ | +197 bps | 14 | 2026-05-14 |
| NXT | Nextpower Inc. Class A Common Stock | 61 | ±0 | Average | -7%↓ | -5%↓ | -201 bps | 56 | 2026-05-19 |
| OCGN | Ocugen, Inc. Common Stock | 61 | ±0 | Average | loss widened 20%↓ | +4% | — | 33 | 2026-05-08 |
| RPID | Rapid Micro Biosystems, Inc. Class A Common Stock | 61 | ±0 | Average | loss widened 19%↓ | +11% | +1537 bps | 17 | 2026-05-15 |
| TXG | 10x Genomics, Inc. Class A Common StockBiotech & Genomics | 61 | ±0 | Average | loss narrowed 64% | -3% | +2154 bps | 97 | 2026-05-08 |
| UG | United-Guardian, Inc. | 61 | ±0 | Average | +50%↑ | +16% | -752 bps | 78 | 2026-05-12 |
| WDFC | Wd-40 Co | 61 | +26 | Average | +45% | +24%↑ | +118 bps | 73 | 2026-07-09 |
| WST | West Pharmaceutical Services, Inc. | 61 | ±0 | Average | +56% | +21% | +120 bps | 82 | 2026-04-23 |
| AMTX | Aemetis, Inc. (DE) Common Stock | 60 | ±0 | Average | loss narrowed 30% | +27%↑ | +618 bps | 48 | 2026-05-07 |
| ANIX | Anixa Biosciences, Inc. | 60 | +31 | Average | loss narrowed 22% | — | — | 64 | 2026-06-10 |
| AUTL | Autolus Therapeutics plc American Depositary Share | 60 | ±0 | Average | loss widened 4% | +192%↓ | — | 49 | 2026-05-14 |
| CBUS | Cibus, Inc. Class A Common Stock | 60 | ±0 | Average | loss narrowed 75% | +63%↑ | — | 47 | 2026-05-14 |
| HYPD | Hyperion DeFi, Inc. Common Stock | 60 | ±0 | Average | to profit | >+999%↓ | — | 33 | 2026-05-15 |
| IMMP | Immutep Limited American Depositary Shares | 60 | ±0 | Average | loss widened 19% | +32% | — | 3 | 2025-10-24 |
| KMDA | Kamada Ltd | 60 | ±0 | Average | 0%↓ | +13% | — | 38 | 2026-03-11 |
| PSTV | PLUS THERAPEUTICS, Inc. Common Stock | 60 | ±0 | Average | loss narrowed 12% | -3%↑ | — | 14 | 2026-05-15 |
| RARE | Ultragenyx Pharmaceutical Inc.Biotech & Genomics | 60 | ±0 | Average | loss widened 17% | -2% | +317 bps | 78 | 2026-05-06 |
| SCNI | Scinai Immunotherapeutics Ltd. American Depositary Shares | 60 | ±0 | Average | to loss | >+999% | — | 5 | 2026-04-01 |
| SGRY | Surgery Partners, Inc. Common Stock | 60 | ±0 | Average | loss narrowed 7% | +4% | +122 bps | 54 | 2026-05-05 |
| TRMB | Trimble Inc. Common Stock | 60 | ±0 | Average | +56%↓ | +12% | +474 bps | 22 | 2026-05-06 |
| ZBH | Zimmer Biomet Holdings, Inc. | 60 | ±0 | Average | +34% | +9% | -302 bps | 55 | 2026-05-01 |
| BFRI | Biofrontera Inc. Common Stock | 59 | ±0 | Average | loss narrowed 13% | +17% | +1713 bps | 81 | 2026-05-14 |
| DVA | DaVita Inc. | 59 | ±0 | Average | +44%↑ | +6% | -69 bps | 97 | 2026-05-05 |
| ILMN | Illumina Inc | 59 | +1 | Average | +6% | +5% | +3226 bps | 82 | 2026-05-04 |
| OTLK | Outlook Therapeutics, Inc. Common Stock | 59 | ±0 | Average | loss narrowed 97% | — | — | 98 | 2026-05-15 |
| PRCT | PROCEPT BioRobotics Corporation Common Stock | 59 | ±0 | Average | loss widened 24% | +20% | +484 bps | 19 | 2026-04-30 |
| BCPC | Balchem Corporation | 58 | ±0 | Average | +11%↓ | +8%↓ | +30 bps | 51 | 2026-04-30 |
| HCA | HCA Healthcare, Inc. | 58 | ±0 | Average | +11% | +4%↓ | +80 bps | 29 | 2026-04-29 |
| HURC | Hurco Cos Inc | 58 | ±0 | Average | loss narrowed 40%↑ | +17%↑ | -54 bps | 81 | 2026-06-05 |
| IBRX | ImmunityBio, Inc. Common Stock | 58 | ±0 | Average | loss widened 313%↓ | +168%↓ | >+10,000 bps | 96 | 2026-05-07 |
| LFMD | LifeMD, Inc. Common Stock | 58 | ±0 | Average | loss widened 900% | -22% | -589 bps | 72 | 2026-05-06 |
| MDXH | MDxHealth SA Ordinary Shares | 58 | ±0 | Average | loss narrowed 42% | +20% | +1410 bps | 3 | 2026-04-03 |
| SILO | Silo Pharma, Inc. Common Stock | 58 | ±0 | Average | loss narrowed 48% | 0% | — | 34 | 2026-05-14 |
| ALTO | Alto Ingredients, Inc. Common Stock | 57 | ±0 | Average | to profit↓ | -1%↑ | +735 bps | 97 | 2026-05-08 |
| CLPT | ClearPoint Neuro, Inc. Common Stock | 57 | ±0 | Average | loss widened 45%↓ | +43%↑ | +205 bps | 58 | 2026-05-13 |
| GELS | Gelteq Limited Ordinary Shares | 57 | ±0 | Average | loss widened 64% | +107% | — | 11 | 2025-11-17 |
| GILD | Gilead Sciences Inc | 57 | ±0 | Average | +55% | +4% | +627 bps | 67 | 2026-05-07 |
| QTRX | Quanterix Corporation Common Stock | 57 | ±0 | Average | loss narrowed 30%↑ | +20% | -4990 bps | 11 | 2026-05-06 |
| STXS | Stereotaxis, Inc. Common Stock | 57 | ±0 | Average | loss narrowed 14% | -16% | +2318 bps | 14 | 2026-05-13 |
| SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | 57 | ±0 | Average | loss narrowed 18% | -1%↓ | — | 32 | 2026-05-15 |
| UTHR | United Therapeutics Corp | 57 | ±0 | Average | -12% | -2% | -159 bps | 70 | 2026-05-06 |
| AME | Ametek, Inc. | 56 | ±0 | Average | +14% | +11% | -26 bps | 66 | 2026-04-30 |
| ANIK | Anika Therapeutics Inc | 56 | ±0 | Average | loss widened 9% | +13% | — | 93 | 2026-04-30 |
| CRDF | Cardiff Oncology, Inc. Common Stock | 56 | ±0 | Average | loss narrowed 10% | -62% | — | 6 | 2026-05-14 |
| CUE | Cue Biopharma, Inc. | 56 | ±0 | Average | loss widened 535% | >+999% | — | 99 | 2026-05-14 |
| IFF | International Flavors & Fragrances Inc. | 56 | +1 | Average | to profit | -4%↑ | +1030 bps | 66 | 2026-05-05 |
| INSP | Inspire Medical Systems, Inc. | 56 | ±0 | Average | to loss | +2% | -32 bps | 15 | 2026-05-04 |
| IRIX | Iridex Corp | 56 | ±0 | Average | loss narrowed 70% | -1% | +1127 bps | 23 | 2026-05-19 |
| OM | Outset Medical, Inc. Common Stock | 56 | ±0 | Average | loss narrowed 72% | -6%↓ | +2339 bps | 29 | 2026-05-07 |
| OPCH | Option Care Health, Inc. Common Stock | 56 | ±0 | Average | +4% | +1% | -67 bps | 18 | 2026-04-30 |
| PGEN | Precigen, Inc. Common Stock | 56 | ±0 | Average | loss narrowed 89%↑ | >+999% | — | 79 | 2026-05-13 |
| SPRY | ARS Pharmaceuticals, Inc. Common Stock | 56 | +1 | Average | loss widened 74% | +184% | <-10,000 bps | 16 | 2026-05-15 |
| TDY | Teledyne Technologies Incorporated | 56 | ±0 | Average | +22% | +8%↑ | +145 bps | 67 | 2026-04-24 |
| YCBD | cbdMD, Inc. Common Stock | 56 | ±0 | Average | loss narrowed 96% | +19%↑ | -205 bps | 15 | 2026-05-14 |
| APD | Air Products & Chemicals, Inc. | 55 | ±0 | Average33 | to profit↑ | +9%↑ | +612 bps | 69 | 2026-04-30 |
| ARDX | Ardelyx, Inc. | 55 | ±0 | Average | loss narrowed 12% | +27% | +220 bps | 25 | 2026-04-30 |
| BIOA | BioAge Labs, Inc. Common Stock | 55 | ±0 | Average | loss widened 44% | +91% | — | 59 | 2026-05-08 |
| CGC | Canopy Growth Corporation Common Shares | 55 | — | Average | loss narrowed 85%↓ | 0%↓ | >+10,000 bps | 29 | 2026-06-15 |
| CLIR | ClearSign Technologies Corporation Common Stock (DE) | 55 | ±0 | Average | loss widened 5%↑ | -52% | — | 9 | 2026-05-15 |
| GRAL | GRAIL, Inc. Common Stock | 55 | ±0 | Average | loss narrowed 26% | +28% | >+10,000 bps | 24 | 2026-05-07 |
| HALO | Halozyme Therapeutics, Inc. | 55 | ±0 | Average | +31% | +42% | -2116 bps | 64 | 2026-05-11 |
| IONS | Ionis Pharmaceuticals, Inc. Common StockBiotech & Genomics | 55 | ±0 | Average | loss narrowed 40% | +87% | — | 23 | 2026-04-29 |
| LCTX | Lineage Cell Therapeutics, Inc. | 55 | ±0 | Average | loss widened 50%↑ | +15% | — | 21 | 2026-05-12 |
| MGRX | Mangoceuticals, Inc. Common Stock | 55 | +1 | Average | loss narrowed 83% | -38% | — | 19 | 2026-05-19 |
| ECL | Ecolab, Inc. | 54 | ±0 | Average | +8% | +10%↑ | -106 bps | 49 | 2026-05-07 |
| ICUI | ICU Medical Inc | 54 | +1 | Average | to profit | -12%↓ | — | 56 | 2026-05-07 |
| MNOV | Medicinova, Inc. | 54 | ±0 | Average | loss narrowed 17% | — | — | 36 | 2026-05-14 |
| OGEN | Oragenics Inc. | 54 | ±0 | Average | loss widened 325% | — | — | 16 | 2026-05-08 |
| SRTA | Strata Critical Medical, Inc. Class A Common Stock | 54 | ±0 | Average | to profit | +24% | +414 bps | 40 | 2026-05-06 |
| TKNO | Alpha Teknova, Inc. Common Stock | 54 | +1 | Average | loss narrowed 11% | +13% | +2144 bps | 89 | 2026-05-07 |
| VTAK | Catheter Precision, Inc. | 54 | +1 | Average | loss widened 286%↓ | +202% | — | 4 | 2026-05-18 |
| IOSP | Innospec Inc. | 53 | +1 | Average | -7% | +3% | -261 bps | 58 | 2026-05-08 |
| LODE | Comstock Inc. | 53 | +1 | Average | loss narrowed 62% | -60%↑ | — | 48 | 2026-05-07 |
| NVO | Novo-Nordisk A/SGLP-1 / Obesity | 53 | ±0 | Average | +2% | +6% | -289 bps | 38 | 2026-02-04 |
| UPC | Universe Pharmaceuticals Inc. Class A Ordinary Shares | 53 | ±0 | Average | loss narrowed 99% | >+999% | +1850 bps | — | 2026-01-29 |
| A | Agilent Technologies Inc. | 52 | ±0 | Average | +60% | +10% | +12 bps | 41 | 2026-06-01 |
| ALC | Alcon Inc. Ordinary Shares | 52 | ±0 | Average | -22% | +4% | +1433 bps | 40 | 2026-05-05 |
| ATAI | AtaiBeckley Inc. Common Stock | 52 | +1 | Average | loss widened 213% | >+999% | — | 96 | 2026-05-12 |
| IMCC | IM Cannabis Corp. Common Shares | 52 | ±0 | Average | loss narrowed 41% | +1% | -223 bps | 2 | 2026-03-30 |
| KEQU | Kewaunee Scientific Corp | 52 | ±0 | Average | -31% | -7%↓ | -146 bps | 49 | 2026-06-26 |
| KVUE | Kenvue Inc. | 52 | ±0 | Average | +47% | +4%↑ | +507 bps | 67 | 2026-05-07 |
| LAB | Standard BioTools Inc. Common Stock | 52 | ±0 | Average | to profit↑ | -48% | -4945 bps | 14 | 2026-05-06 |
| NMTC | NeuroOne Medical Technologies Corporation Common Stock | 52 | ±0 | Average | loss widened 300%↓ | +34% | — | 8 | 2026-05-12 |
| NNOX | NANO-X IMAGING LTD Ordinary Shares | 52 | ±0 | Average | loss widened 27% | +15% | -9790 bps | 7 | 2026-04-30 |
| WAT | Waters Corp | 52 | ±0 | Average | to loss | +91% | -1229 bps | 42 | 2026-05-12 |
| ALGN | Align Technology Inc | 51 | ±0 | Average | +24% | +6%↑ | -110 bps | 57 | 2026-05-06 |
| BKD | Brookdale Senior Living, Inc. | 51 | ±0 | Average | loss narrowed 89%↑ | -6%↓ | -67 bps | 86 | 2026-05-07 |
| CSW | CSW Industrials, Inc. | 51 | +1 | Average | -40% | +34% | -507 bps | 35 | 2026-05-26 |
| EQ | Equillium, Inc. Common Stock | 51 | ±0 | Average | loss narrowed 75% | -52%↓ | — | 98 | 2026-05-13 |
| EVGN | EVOGENE LTD. | 51 | +1 | Average | to profit | -55% | — | 13 | 2026-03-26 |
| GCTK | GlucoTrack, Inc. Common Stock | 51 | +2 | Average | to profit | -100%↓ | — | 2 | 2026-05-14 |
| HIMS | Hims & Hers Health, Inc.GLP-1 / Obesity | 51 | +1 | Average | to loss | +4%↓ | -745 bps | 61 | 2026-05-11 |
| HRMY | Harmony Biosciences Holdings, Inc. Common Stock | 51 | ±0 | Average | -29% | +17%↓ | -511 bps | 44 | 2026-05-07 |
| PCT | PureCycle Technologies, Inc. Common stock | 51 | ±0 | Average | to loss | +161% | — | 14 | 2026-05-06 |
| TDOC | Teladoc Health, Inc. | 51 | ±0 | Average | loss narrowed 32% | -2% | +3318 bps | 91 | 2026-04-30 |
| UPB | Upstream Bio, Inc. Common Stock | 51 | ±0 | Average | loss widened 47% | +83% | — | 4 | 2026-05-13 |
| ASPI | ASP Isotopes Inc. Common StockNuclear / SMR | 50 | +1 | Average | loss narrowed 50% | +279% | — | 13 | 2026-05-20 |
| FENC | Fennec Pharmaceuticals Inc. Common Stock | 50 | ±0 | Average | to profit | +73%↓ | +2780 bps | 86 | 2026-05-14 |
| FUL | H.B. Fuller Company | 50 | ±0 | Average | +62% | +6%↑ | — | 39 | 2026-06-25 |
| KURA | Kura Oncology, Inc. | 50 | ±0 | Average | loss widened 57% | +25% | -9140 bps | 77 | 2026-05-12 |
| LIVN | LivaNova PLC Ordinary Shares | 50 | ±0 | Average | to profit | +14% | +75 bps | 81 | 2026-05-06 |
| PLSE | Pulse Biosciences, Inc Common Stock (DE) | 50 | +1 | Average | loss widened 8% | — | — | 97 | 2026-05-14 |
| SBC | SBC Medical Group Holdings Incorporated Common Stock | 50 | +1 | Average | -48%↓ | -9%↑ | -1198 bps | 22 | 2026-05-14 |
| STVN | Stevanato Group S.p.A. | 50 | ±0 | Average | +19% | +7% | +216 bps | 43 | 2026-03-04 |
| EDIT | Editas Medicine, Inc. Common Stock | 49 | +1 | Average | loss narrowed 72% | -39%↓ | >+10,000 bps | 87 | 2026-05-05 |
| ELF | e.l.f. Beauty, Inc. | 49 | ±0 | Average | to loss | +35% | — | 41 | 2026-05-21 |
| IPAR | Interparfums, Inc. Common Stock | 49 | ±0 | Average | +2% | +2% | -119 bps | 87 | 2026-05-05 |
| MASS | 908 Devices Inc. Common Stock | 49 | ±0 | Average | to loss | +14%↑ | +5079 bps | 83 | 2026-05-06 |
| MD | Pediatrix Medical Group, Inc. | 49 | +1 | Average | +50% | +4%↑ | +1396 bps | 71 | 2026-05-05 |
| PPBT | Purple Biotech Ltd. American Depositary Shares | 49 | +1 | Average | -99% | 0% | — | 4 | 2026-03-19 |
| TLX | Telix Pharmaceuticals Limited American Depositary Shares | 49 | +1 | Average | to loss | +56% | — | 89 | 2026-02-20 |
| TRLV | Trulieve Cannabis Corp. | 49 | +1 | Average | to profit | -4%↓ | +530 bps | — | 2026-05-07 |
| TT | Trane Technologies plcData Center Power | 49 | ±0 | Average | -2%↓ | +6%↑ | +2 bps | 78 | 2026-04-30 |
| WNW | Meiwu Technology Company Limited Ordinary Shares | 49 | ±0 | Average | to loss | >+999% | — | — | 2026-04-17 |
| ACB | Aurora Cannabis Inc. Common Shares | 48 | ±0 | Average | -89% | +27% | +1863 bps | 18 | 2026-06-11 |
| AIRS | AirSculpt Technologies, Inc. Common Stock | 48 | ±0 | Average | loss narrowed 40% | 0%↑ | +62 bps | 97 | 2026-05-08 |
| CSTL | Castle Biosciences, Inc. Common Stock | 48 | ±0 | Average | loss narrowed 46%↑ | -5% | -582 bps | 17 | 2026-05-06 |
| DGX | Quest Diagnostics Inc. | 48 | ±0 | Average | +15%↑ | +9% | +56 bps | 66 | 2026-04-22 |
| DRS | Leonardo DRS, Inc. Common StockDefense / Drones | 48 | +1 | Average | +21% | +6%↓ | +67 bps | 61 | 2026-05-05 |
| MDT | Medtronic plc | 48 | ±0 | Average | +19% | +10%↑ | +3 bps | 36 | 2026-06-18 |
| MSA | Mine Safety Incorporated | 48 | ±0 | Average | +21% | +10% | -111 bps | 46 | 2026-05-05 |
| MYO | Myomo Inc. | 48 | ±0 | Average | loss narrowed 12%↑ | +3% | -1895 bps | 47 | 2026-05-07 |
| PBH | Prestige Consumer Healthcare Inc. | 48 | ±0 | Average | +13%↑ | -5% | -118 bps | 29 | 2026-05-14 |
| PTGX | Protagonist Therapeutics, Inc | 48 | +1 | Average | to profit | +99% | <-10,000 bps | 93 | 2026-05-05 |
| VRCA | Verrica Pharmaceuticals Inc. Common Stock | 48 | ±0 | Average | loss widened 350% | +46%↓ | — | 25 | 2026-05-12 |
| ACON | Aclarion, Inc. Common Stock | 47 | ±0 | Average | loss narrowed 86% | +11% | — | 20 | 2026-05-13 |
| CBLL | CeriBell, Inc. Common Stock | 47 | +1 | Average | loss widened 44% | +29% | -476 bps | 32 | 2026-05-11 |
| HCWB | HCW Biologics Inc. Common Stock | 47 | +1 | Average | to profit | >+999%↑ | — | 15 | 2026-05-14 |
| JNJ | Johnson & Johnson | 47 | ±0 | Average | -53%↓ | +10%↑ | -747 bps | 71 | 2026-04-22 |
| MIR | Mirion Technologies, Inc. | 47 | ±0 | Average | to loss↓ | +28%↑ | +33 bps | 16 | 2026-04-29 |
| MITQ | Moving iMage Technologies, Inc. | 47 | ±0 | Average | loss narrowed 50% | -5% | +528 bps | 24 | 2026-05-14 |
| NEPH | Nephros Inc. | 47 | ±0 | Average | -80%↓ | +7%↓ | -144 bps | 35 | 2026-05-07 |
| NNNN | Anbio Biotechnology Class A Ordinary Shares | 47 | ±0 | Average | +163% | +6% | — | 5 | 2026-04-07 |
| PLUR | Pluri Inc. Common Stock | 47 | ±0 | Average | loss narrowed 41% | -61% | — | 15 | 2026-05-14 |
| PRM | Perimeter Solutions, Inc. | 47 | ±0 | Average | +22% | +74%↑ | -5516 bps | 75 | 2026-05-06 |
| SMTI | Sanara MedTech Inc. Common Stock | 47 | ±0 | Average | to profit↑ | +19% | +1913 bps | 61 | 2026-05-12 |
| SUPN | Supernus Pharmaceuticals, Inc. | 47 | ±0 | Average | loss narrowed 81%↑ | +39%↑ | -1893 bps | 47 | 2026-05-05 |
| CDRE | Cadre Holdings, Inc. | 46 | ±0 | Average | -78%↓ | +19% | -256 bps | 21 | 2026-05-11 |
| COHU | Cohu Inc | 46 | ±0 | Average | loss narrowed 61% | +29%↓ | +959 bps | 95 | 2026-05-01 |
| DERM | Journey Medical Corporation Common Stock | 46 | ±0 | Average | loss narrowed 56% | +21% | +261 bps | 36 | 2026-05-13 |
| EUDA | EUDA Health Holdings Limited Ordinary Shares | 46 | +1 | Average | loss widened 215% | +70% | — | 6 | 2026-04-28 |
| INBS | Intelligent Bio Solutions Inc. Common Stock | 46 | +1 | Average | loss widened 309% | +46% | — | 3 | 2026-05-13 |
| OPXS | Optex Systems Holdings, INC | 46 | ±0 | Average | -27% | -10%↓ | -214 bps | 31 | 2026-05-11 |
| POCI | Precision Optics Corporation, Inc. Common Stock | 46 | ±0 | Average | loss narrowed 97% | +108%↑ | +1505 bps | 51 | 2026-05-13 |
| RVTY | Revvity, Inc. | 46 | ±0 | Average | +3% | +7%↑ | -112 bps | 44 | 2026-05-12 |
| XAIR | Beyond Air, Inc. Common Stock | 46 | ±0 | Average | — | — | — | 4 | 2026-06-26 |
| XTNT | Xtant Medical Holdings, Inc. | 46 | +1 | Average | to loss↓ | -37%↓ | +887 bps | 23 | 2026-05-13 |
| ELSE | Electro-Sensors Inc | 45 | +1 | Average | loss widened 50% | +15%↑ | — | 96 | 2026-05-14 |
| IPSC | Century Therapeutics, Inc. Common Stock | 45 | ±0 | Average | to loss | -100% | — | 47 | 2026-05-13 |
| LFCR | Lifecore Biomedical, Inc. Common Stock | 45 | ±0 | Average | loss narrowed 9% | -34% | +2533 bps | 16 | 2026-05-06 |
| MNKD | Mannkind Corporation | 45 | ±0 | Average | to loss | +15% | -2215 bps | 25 | 2026-05-06 |
| PAVM | PAVmed Inc. Common Stock | 45 | ±0 | Average | to loss↓ | +175% | — | 21 | 2026-05-14 |
| REGN | Regeneron Pharmaceuticals IncGLP-1 / Obesity | 45 | ±0 | Average | -7%↓ | +19%↑ | -287 bps | 42 | 2026-04-29 |
| UL | Unilever plc | 45 | +1 | Average | +89% | -17% | +242 bps | 49 | 2026-03-12 |
| VVOS | Vivos Therapeutics, Inc. Common Stock | 45 | +1 | Average | loss widened 16% | +70% | -3817 bps | 4 | 2026-05-20 |
| ERNA | Ernexa Therapeutics Inc. Common Stock | 44 | ±0 | Average | loss widened 999%↓ | — | — | 4 | 2026-05-11 |
| GKOS | Glaukos Corporation | 44 | ±0 | Average | loss widened 6% | +41% | -1035 bps | 87 | 2026-04-30 |
| GUTS | Fractyl Health, Inc. Common Stock | 44 | +1 | Average | to profit↑ | -57% | — | 8 | 2026-05-12 |
| SRZN | Surrozen, Inc. Common | 44 | ±0 | Average | loss widened 57%↑ | +409%↑ | — | 68 | 2026-05-06 |
| VLTO | Veralto Corporation | 44 | ±0 | Average | +13%↑ | +7% | -31 bps | 42 | 2026-04-29 |
| BNKK | Bonk, Inc. Common Stock | 43 | +1 | Average | loss widened 188% | >+999% | — | 6 | 2026-05-13 |
| CYRX | CryoPort, Inc. Common Stock | 43 | +1 | Average | loss narrowed 11% | +16% | +3523 bps | 88 | 2026-05-05 |
| DHR | Danaher Corporation | 43 | ±0 | Average | +10%↓ | +4% | -105 bps | 35 | 2026-04-21 |
| EW | Edwards Lifesciences Corp | 43 | ±0 | Average | +8%↑ | +17% | -373 bps | 54 | 2026-05-06 |
| LIN | Linde plc Ordinary Share | 43 | ±0 | Average | +13% | +8%↑ | +6 bps | 73 | 2026-05-01 |
| LUNG | Pulmonx Corporation Common Stock | 43 | +1 | Average | loss narrowed 8% | -9%↓ | +721 bps | 27 | 2026-05-04 |
| MTD | Mettler-Toledo International | 43 | ±0 | Average | +7% | +7% | -76 bps | 37 | 2026-05-08 |
| SXT | Sensient Technology Corporation | 43 | +1 | Average | +28% | +11% | +80 bps | 70 | 2026-05-05 |
| VNRX | VolitionRx Limited | 43 | ±0 | Average | loss widened 999%↓ | +300%↑ | — | 4 | 2026-05-14 |
| BBLG | Bone Biologics Corp Common Stock | 42 | +1 | Average | loss widened 34%↓ | — | — | 22 | 2026-05-14 |
| BDRX | Biodexa Pharmaceuticals plc American Depositary Shs | 42 | ±0 | Average | loss narrowed 90% | -45% | — | 4 | 2026-03-27 |
| CAMT | Camtek Ltd | 42 | ±0 | Average | -57% | +16% | +67 bps | 57 | 2026-03-19 |
| CITR | CitroTech Inc. | 42 | +1 | Average | loss widened 43%↑ | -64% | — | 18 | 2026-05-15 |
| DD | DuPont de Nemours, Inc. Common Stock | 42 | ±0 | Average | to profit↑ | +4% | -513 bps | 60 | 2026-05-05 |
| ESI | Element Solutions Inc. | 42 | +1 | Average | -43% | +41%↑ | -43 bps | 80 | 2026-04-29 |
| IMDX | Insight Molecular Diagnostics Inc. Common Stock | 42 | +1 | Average | loss narrowed 54% | -99%↓ | — | 26 | 2026-05-13 |
| KALA | KALA BIO, Inc. Common Stock | 42 | ±0 | Average | loss narrowed 90% | -100%↓ | — | 1 | 2026-05-15 |
| MTX | Minerals Technologies Inc | 42 | +1 | Average | to profit | +11% | +1004 bps | 64 | 2026-05-01 |
| AMRN | Amarin Corp Plc | 41 | ±0 | Average | loss narrowed 25% | +7% | +2371 bps | 43 | 2026-04-29 |
| IDYA | IDEAYA Biosciences, Inc. Common Stock | 41 | +1 | Average | loss widened 35%↓ | — | — | 51 | 2026-05-05 |
| INGN | Inogen Inc | 41 | ±0 | Average | loss widened 20% | +6% | +127 bps | 52 | 2026-05-08 |
| MLSS | Milestone Scientific, Inc. Common Stock | 41 | ±0 | Average | loss narrowed 50% | -3% | — | 90 | 2026-05-13 |
| NVCR | NovoCure Limited Ordinary Shares | 41 | ±0 | Average | loss widened 100% | +12%↑ | -35 bps | 73 | 2026-04-30 |
| SINT | SiNtx Technologies, Inc. Common Stock | 41 | +1 | Average | loss narrowed 46% | +3%↑ | — | 9 | 2026-05-15 |
| TECH | Bio-Techne Corp. | 41 | ±0 | Average | +129% | -2% | -153 bps | 57 | 2026-05-06 |
| TRNS | Transcat Inc | 41 | +1 | Average | -59% | +45% | -242 bps | 86 | 2026-05-27 |
| CCCC | C4 Therapeutics, Inc. | 40 | ±0 | Average | loss narrowed 46% | -15% | — | 93 | 2026-05-12 |
| CDIO | Cardio Diagnostics Holdings Inc. Common stock | 40 | +1 | Average | loss narrowed 35% | +185%↑ | — | 45 | 2026-05-15 |
| CYH | Community Health Systems, Inc. | 40 | ±0 | Average | loss widened 330% | -6%↓ | +738 bps | 46 | 2026-04-22 |
| DBVT | DBV Technologies S.A. | 40 | -32 | Average | loss narrowed 61%↑ | -52%↓ | — | 29 | new filing |
| GANX | Gain Therapeutics, Inc. Common Stock | 40 | +1 | Average | loss narrowed 19% | — | — | 38 | 2026-05-11 |
| LH | Labcorp Holdings Inc. | 40 | ±0 | Average | +33% | +6% | +189 bps | 61 | 2026-05-04 |
| RDNT | RadNet, Inc. Common Stock | 40 | ±0 | Average | loss narrowed 16% | +22%↑ | -80 bps | 34 | 2026-05-11 |
| RDY | Dr. Reddy's Laboratories Limited American Depositary Shares | 40 | ±0 | Average | -80% | +17% | -219 bps | 48 | 2026-05-29 |
| REX | REX American Resources Corp. | 40 | ±0 | Average | +10% | -1%↓ | — | 87 | 2026-06-02 |
| SABS | SAB Biotherapeutics, Inc. Common Stock | 40 | ±0 | Average | loss narrowed 38% | -62% | — | 39 | 2026-05-12 |
| SENS | Senseonics Holdings, Inc. Common Stock | 40 | ±0 | Average | loss widened 999% | +87% | +8304 bps | 24 | 2026-05-07 |
| XLO | Xilio Therapeutics, Inc. Common Stock | 40 | ±0 | Average | loss widened 222% | +332% | — | 48 | 2026-05-12 |
| BLRX | BioLineRX Ltd | 39 | +1 | Average | to profit | -96% | — | 51 | 2026-03-23 |
| KRMD | KORU Medical Systems, Inc. Common Stock (DE) | 39 | +1 | Average | to loss | +22%↓ | +1034 bps | 25 | 2026-05-06 |
| LEXX | Lexaria Bioscience Corp. Common Stock | 39 | +1 | Average | loss narrowed 62%↑ | -100% | — | 33 | new filing |
| MIRM | Mirum Pharmaceuticals, Inc. Common Stock | 39 | +1 | Average | loss widened 999%↓ | +43% | <-10,000 bps | 82 | 2026-05-06 |
| MNPR | Monopar Therapeutics Inc. Common Stock | 39 | +1 | Average | loss widened 21% | — | — | 92 | 2026-05-14 |
| RPM | RPM International, Inc. | 39 | +1 | Average | 0% | +9% | +150 bps | 42 | 2026-04-08 |
| SNDA | Sonida Senior Living, Inc. | 39 | +1 | Average | loss widened 210%↓ | +33% | -5120 bps | 82 | 2026-05-11 |
| TMO | Thermo Fisher Scientific, Inc. | 39 | ±0 | Average | +11%↑ | +6% | +24 bps | 36 | 2026-05-01 |
| AXGN | Axogen, Inc. Common Stock | 38 | +1 | Average | loss widened 375%↓ | +27% | -359 bps | 82 | 2026-04-28 |
| BMRN | BioMarin Pharmaceuticals Inc | 38 | ±0 | Average | -43% | +3% | -1128 bps | 64 | 2026-05-05 |
| CTSO | Cytosorbents Corp. | 38 | ±0 | Average | loss widened 300% | +2% | +822 bps | 14 | 2026-05-13 |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | 38 | ±0 | Average | +18% | -2% | +223 bps | 58 | 2026-03-13 |
| MMED | MiniMed Group, Inc. Common Stock | 38 | — | Average | loss widened 55% | +14% | — | — | 2026-06-29 |
| NVAX | Novavax Inc | 38 | ±0 | Average | to loss | -79% | -4589 bps | 55 | 2026-05-06 |
| RAL | Ralliant Corporation | 38 | ±0 | Average | -32% | +11% | — | 84 | 2026-05-12 |
| ZTS | ZOETIS INC. | 38 | ±0 | Average | +1%↓ | +2% | +37 bps | 18 | 2026-05-07 |
| CRIS | Curis Inc | 37 | ±0 | Average | loss widened 0% | -100%↓ | — | 5 | 2026-05-13 |
| GYRE | Gyre Therapeutics, Inc. Common Stock | 37 | ±0 | Average | to loss | +2% | -1042 bps | 28 | 2026-05-08 |
| IBIO | iBio, Inc. Common Stock | 37 | +1 | Average | loss narrowed 88%↑ | — | — | 18 | 2026-05-12 |
| SNGX | Soligenix, Inc. Common Stock | 37 | ±0 | Average | loss narrowed 71% | -100% | — | 5 | 2026-05-08 |
| UFPT | UFP Technologies Inc | 37 | ±0 | Average | +1% | +4% | -88 bps | 48 | 2026-05-08 |
| BRTX | BioRestorative Therapies, Inc. Common Stock (NV) | 36 | ±0 | Average | loss narrowed 81%↑ | -7%↑ | — | 6 | 2026-05-14 |
| INNV | InnovAge Holding Corp. Common Stock | 36 | ±0 | Average | loss widened 175%↓ | +15% | +289 bps | 96 | 2026-05-08 |
| OWLT | Owlet, Inc. | 36 | ±0 | Average | to loss | +6%↓ | +996 bps | 9 | 2026-05-11 |
| TVRD | Tvardi Therapeutics, Inc. Common Stock | 36 | ±0 | Average | loss narrowed 77% | +20% | — | 20 | 2026-05-08 |
| VSEE | VSee Health, Inc. Common Stock | 36 | ±0 | Average | loss narrowed 79%↓ | -5% | — | 4 | 2026-05-15 |
| CHD | Church & Dwight Co., Inc. | 35 | ±0 | Average | +2% | 0%↓ | +416 bps | 65 | 2026-05-01 |
| CNMD | CONMED Corporation | 35 | ±0 | Average | -50% | +8%↑ | -786 bps | 57 | 2026-04-30 |
| CODX | Co-Diagnostics, Inc. Common Stock | 35 | ±0 | Average | loss widened 999% | +190%↑ | — | 35 | 2026-05-14 |
| LNZA | LanzaTech Global, Inc. Common Stock | 35 | ±0 | Average | loss widened 999% | +27% | >+10,000 bps | 8 | 2026-05-14 |
| LOOP | Loop Industries, Inc. Common Stock | 35 | -42 | Average | loss widened 0% | -29% | — | 21 | new filing |
| AGL | agilon health, inc. | 34 | +1 | Average | +303% | -7% | -238 bps | 99 | 2026-05-06 |
| AMS | American Shared Hospital Services | 34 | ±0 | Average | loss narrowed 10%↓ | +16% | +269 bps | 23 | 2026-05-14 |
| BDSX | Biodesix, Inc. Common Stock | 34 | ±0 | Average | loss widened 913% | +42%↑ | +1785 bps | 98 | 2026-05-04 |
| CHRS | Coherus Oncology, Inc. Common Stock | 34 | ±0 | Average | loss narrowed 43%↑ | +62%↑ | <-10,000 bps | 37 | 2026-05-11 |
| CORT | Corcept Therapeutics Inc.Biotech & Genomics | 34 | ±0 | Average | to loss | +5%↓ | -1724 bps | 98 | 2026-04-30 |
| LPCN | Lipocine Inc. | 34 | ±0 | Average | loss widened 54% | +27%↑ | — | 4 | 2026-05-07 |
| PG | Procter & Gamble Company | 34 | ±0 | Average | +6% | +7% | -57 bps | 58 | 2026-04-24 |
| RMTI | Rockwell Medical, Inc. (DE) Common Stock | 34 | +1 | Average | loss widened 0% | -8%↑ | -769 bps | 21 | 2026-05-07 |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 34 | ±0 | Average | -26% | +7% | +246 bps | 60 | 2026-06-17 |
| VYNE | VYNE Therapeutics Inc. Common Stock | 34 | ±0 | Average | loss narrowed 60%↑ | -57% | — | 89 | 2026-05-15 |
| APRE | Aprea Therapeutics, Inc. Common stock | 33 | ±0 | Average | loss narrowed 67%↑ | -98% | — | 27 | 2026-05-13 |
| BIO | Bio-Rad Laboratories, Inc.Class A | 33 | +1 | Average | to loss | +1% | — | 46 | 2026-04-30 |
| DSGN | Design Therapeutics, Inc. Common Stock | 33 | ±0 | Average | loss narrowed 6%↑ | — | — | 82 | 2026-04-28 |
| GEHC | GE HealthCare Technologies Inc. Common Stock | 33 | ±0 | Average | -31%↓ | +7%↑ | -108 bps | 28 | 2026-04-29 |
| GOVX | GeoVax Labs, Inc. New | 33 | ±0 | Average | loss widened 482% | -100% | — | 7 | 2026-05-14 |
| KZIA | Kazia Therapeutics Limited American Depositary Shares | 33 | ±0 | Average | loss narrowed 63% | -98% | — | 96 | 2025-11-07 |
| VNT | Vontier Corporation | 33 | ±0 | Average | +12% | +1% | +65 bps | 29 | 2026-05-07 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 33 | ±0 | Average | loss widened 839%↓ | +17%↓ | -1064 bps | 15 | 2026-05-04 |
| WOK | WORK Medical Technology Group LTD Class A Ordinary Shares | 33 | ±0 | Average | loss narrowed 85% | -14% | — | — | 2026-01-30 |
| APT | Alpha Pro Tech, Ltd. | 32 | ±0 | Average | +17% | +6% | +47 bps | 68 | 2026-05-07 |
| CHE | Chemed Corporation | 32 | +1 | Average | 0%↑ | +2% | -271 bps | 69 | 2026-04-28 |
| CSBR | Champions Oncology, Inc. | 32 | ±0 | Average | to loss | -3% | -1526 bps | 36 | 2026-03-12 |
| GNLX | Genelux Corporation Common Stock | 32 | ±0 | Average | loss narrowed 5%↑ | — | — | 72 | 2026-05-07 |
| ICCC | Immucell Corp | 32 | ±0 | Average | +31% | +28%↑ | +917 bps | 94 | 2026-05-14 |
| IMRX | Immuneering Corporation Class A Common Stock | 32 | ±0 | Average | loss narrowed 50% | -100% | — | 44 | 2026-05-15 |
| INO | Inovio Pharmaceuticals, Inc. | 32 | ±0 | Average | loss narrowed 45% | -100% | — | 23 | 2026-05-13 |
| PULM | Pulmatrix, Inc. Common Stock | 32 | +25 | Average | loss narrowed 36%↓ | -100%↓ | — | 21 | 2026-05-15 |
| VTRS | Viatris Inc. Common Stock | 32 | ±0 | Average33 | to profit↑ | +8%↑ | +2250 bps | 85 | 2026-05-07 |
| EL | The Estee Lauder Companies Inc. Class A | 31 | ±0 | Average | -45%↓ | +5% | +714 bps | 26 | 2026-05-01 |
| KIDS | OrthoPediatrics Corp. Common Stock | 31 | ±0 | Average | loss narrowed 2% | +13% | +203 bps | 60 | 2026-05-01 |
| MDXG | MiMedx Group, Inc | 31 | +1 | Average | to loss↓ | -33%↓ | -514 bps | 28 | 2026-04-29 |
| PIII | P3 Health Partners Inc. Common Stock | 31 | +1 | Average | to profit↑ | +4% | +599 bps | 99 | 2026-05-14 |
| WALD | Waldencast plc Class A Ordinary Share | 31 | ±0 | Average | loss widened 415% | -1% | -5857 bps | 58 | 2026-03-13 |
| ACRS | Aclaris Therapeutics, Inc. | 30 | +1 | Average | loss widened 25% | +37% | — | 97 | 2026-05-07 |
| AVR | Anteris Technologies Global Corp. Common Stock | 30 | +1 | Laggard | loss narrowed 54% | -11%↑ | — | 95 | 2026-05-12 |
| CL | Colgate-Palmolive Company | 30 | +1 | Average | -6% | +8%↑ | -618 bps | 65 | 2026-05-01 |
| CLX | Clorox Company | 30 | ±0 | Average33 | +3%↑ | 0%↑ | +118 bps | 38 | 2026-04-30 |
| CRSP | CRISPR Therapeutics AGBiotech & Genomics | 30 | ±0 | Average | loss narrowed 19% | +69% | — | 38 | 2026-05-04 |
| ELUT | Elutia Inc. Class A Common Stock | 30 | ±0 | Average | loss narrowed 19% | -48%↓ | — | 71 | 2026-05-15 |
| IGC | IGC Pharma, Inc. | 30 | +1 | Average | loss widened 0% | -42% | — | 44 | 2026-05-15 |
| INBX | Inhibrx Biosciences, Inc. Common Stock | 30 | ±0 | Average | loss narrowed 23% | -100% | — | 74 | 2026-05-14 |
| SLSN | Solesence, Inc. Common Stock | 30 | ±0 | Average | to loss | -11% | -615 bps | 10 | 2026-05-12 |
| TRAW | Traws Pharma, Inc. Common Stock | 30 | ±0 | Average | to loss | -100% | — | 7 | 2026-05-15 |
| USPH | US Physical Therapy Inc | 30 | ±0 | Average | to loss | +8%↓ | +20 bps | 36 | 2026-05-08 |
| ALXO | ALX Oncology Holdings Inc. Common Stock | 29 | +1 | Laggard | loss narrowed 71% | — | — | 93 | 2026-05-08 |
| ARDT | Ardent Health, Inc. | 29 | ±0 | Laggard | -3%↑ | +7% | -186 bps | 74 | 2026-05-06 |
| ELOX | Eloxx Pharmaceuticals, Inc. Common Stock | 29 | ±0 | Laggard | loss narrowed 42% | -100% | — | — | 2026-05-05 |
| LFWD | Lifeward Ltd. Ordinary Shares | 29 | ±0 | Laggard | loss widened 999%↓ | -11% | — | 39 | 2026-05-20 |
| QSI | Quantum-Si Incorporated Class A Common Stock | 29 | +1 | Laggard | loss narrowed 9% | -69%↓ | — | 21 | 2026-05-07 |
| SOLV | Solventum Corporation | 29 | ±0 | Laggard | -91%↓ | -3% | +1583 bps | 51 | 2026-05-05 |
| YDES | YD Bio Limited Ordinary Shares | 29 | ±0 | Laggard | loss widened 500% | +17% | — | 4 | 2026-04-30 |
| AMPH | Amphastar Pharmaceuticals, Inc. | 28 | ±0 | Laggard | -73% | 0% | -1045 bps | 28 | 2026-05-07 |
| BNTC | Benitec Biopharma Inc. Common Stock | 28 | ±0 | Laggard | loss widened 0%↑ | — | — | 57 | 2026-05-14 |
| CLGN | CollPlant Biotechnologies Ltd Ordinary Shares | 28 | ±0 | Laggard | -24% | -28% | — | 4 | 2026-03-26 |
| FATE | Fate Therapeutics, Inc. | 28 | ±0 | Laggard | loss narrowed 19% | -20%↑ | — | 98 | 2026-05-13 |
| GRCE | Grace Therapeutics, Inc. Common Stock | 28 | ±0 | Laggard | loss narrowed 41% | -100% | — | 21 | 2026-06-18 |
| PBYI | PUMA BIOTECHNOLOGY INC | 28 | ±0 | Laggard | to loss | -3% | -303 bps | 84 | 2026-05-07 |
| ACET | Adicet Bio, Inc. Common Stock | 27 | ±0 | Laggard | loss widened 506% | -100% | — | 52 | 2026-05-13 |
| ALKS | Alkermes Inc. plc | 27 | ±0 | Laggard | to loss↓ | +28% | -1356 bps | 94 | 2026-05-05 |
| AVNS | Avanos Medical, Inc. | 27 | ±0 | Laggard | -21% | +9% | +4777 bps | 97 | 2026-05-05 |
| BRKR | Bruker Corporation | 27 | ±0 | Laggard | -82% | +3%↑ | -504 bps | 71 | 2026-05-07 |
| COO | The Cooper Companies, Inc. Common Stock | 27 | ±0 | Laggard | to loss | +8%↑ | -723 bps | 38 | 2026-06-05 |
| LSTA | Lisata Therapeutics, Inc. Common Stock | 27 | +1 | Laggard | loss narrowed 9% | — | — | 94 | 2026-05-11 |
| RXST | RxSight, Inc. Common Stock | 27 | +1 | Laggard | loss widened 90%↓ | -18% | -1856 bps | 16 | 2026-05-06 |
| SERA | Sera Prognostics, Inc. Class A Common Stock | 27 | ±0 | Laggard | loss narrowed 15% | -63%↓ | — | 17 | 2026-05-06 |
| ABT | Abbott Laboratories | 26 | ±0 | Laggard | -20% | +8% | +23 bps | 34 | 2026-04-29 |
| AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | 26 | ±0 | Laggard | loss narrowed 12%↓ | — | — | 84 | 2026-05-07 |
| ATNM | Actinium Pharmaceuticals, Inc | 26 | ±0 | Laggard | loss narrowed 65% | — | — | 22 | 2026-05-08 |
| ATRA | Atara Biotherapeutics, Inc | 26 | ±0 | Laggard | to loss↓ | -99%↓ | -2056 bps | 95 | 2026-05-12 |
| ICCM | IceCure Medical Ltd. Ordinary Shares | 26 | ±0 | Laggard | -20% | +3% | — | — | 2026-03-17 |
| JANX | Janux Therapeutics, Inc. Common Stock | 26 | ±0 | Laggard | loss widened 3% | — | — | 74 | 2026-05-07 |
| TLRY | Tilray Brands, Inc. Common Stock | 26 | ±0 | Laggard | loss narrowed 72% | +11% | -6083 bps | 9 | 2026-04-01 |
| TXMD | TherapeuticsMD, Inc. | 26 | ±0 | Laggard | to profit | +84% | — | 46 | 2026-05-12 |
| ANGO | AngioDynamics, Inc. | 25 | -6 | Laggard | loss widened 87%↓ | +8%↓ | +119 bps | 80 | new filing |
| ANVS | Annovis Bio, Inc. | 25 | ±0 | Laggard | loss widened 97%↓ | — | — | 13 | 2026-05-15 |
| ARMP | Armata Pharmaceuticals, Inc. Common Stock | 25 | ±0 | Laggard | loss widened 999% | +61%↑ | — | 31 | 2026-05-13 |
| AVD | American Vanguard Corporation | 25 | ±0 | Laggard | loss narrowed 53% | +7% | +1698 bps | 16 | 2026-05-06 |
| AXTA | Axalta Coating Systems Ltd. | 25 | ±0 | Laggard | -7% | -1% | -71 bps | 48 | 2026-04-30 |
| BMI | Badger Meter, Inc. | 25 | ±0 | Laggard | -28%↓ | -9%↓ | -117 bps | 38 | 2026-04-20 |
| CAMP | CAMP4 Therapeutics Corporation Common Stock | 25 | ±0 | Laggard | loss narrowed 48% | +51%↑ | — | 16 | 2026-05-07 |
| IKT | Inhibikase Therapeutics, Inc. Common Stock | 25 | ±0 | Laggard | loss narrowed 33% | — | — | 86 | 2026-05-12 |
| MBIO | Mustang Bio, Inc. | 25 | ±0 | Laggard | loss widened 180% | — | — | 18 | 2026-05-05 |
| MYGN | Myriad Genetics Inc | 25 | ±0 | Laggard | to loss | +2%↑ | -3192 bps | 50 | 2026-05-06 |
| NEU | NewMarket Corporation | 25 | ±0 | Laggard | -5% | -4% | -226 bps | 77 | 2026-04-23 |
| PCRX | Pacira BioSciences, Inc. Common Stock | 25 | ±0 | Laggard | -30% | +5%↓ | +1532 bps | 79 | 2026-04-30 |
| SRRK | Scholar Rock Holding Corporation Common StockGLP-1 / Obesity | 25 | ±0 | Laggard | loss widened 24% | — | — | 65 | 2026-05-07 |
| ZNTL | Zentalis Pharmaceuticals, Inc. Common Stock | 25 | ±0 | Laggard | loss narrowed 25%↓ | -100% | — | 93 | 2026-05-12 |
| ZTEK | Zentek Ltd. Common Stock | 25 | ±0 | Laggard | loss narrowed 17% | -79% | — | 13 | 2026-06-25 |
| AKBA | Akebia Therapeutics, Inc. | 24 | ±0 | Laggard | to loss↓ | -7%↓ | +1419 bps | 48 | 2026-05-07 |
| ALB | Albemarle CorporationCritical Minerals | 24 | ±0 | Laggard | to profit | +33%↑ | +2817 bps | 22 | 2026-05-06 |
| GLAS | Glass House Brands Inc. | 24 | — | Laggard | loss widened 162% | -9% | -1194 bps | — | 2026-05-13 |
| KYMR | Kymera Therapeutics, Inc. Common StockBiotech & Genomics | 24 | ±0 | Laggard | loss narrowed 13%↑ | +55% | <-10,000 bps | 93 | 2026-04-30 |
| ONTO | Onto Innovation Inc.Semiconductors | 24 | ±0 | Laggard | -48%↓ | +10% | +159 bps | 83 | 2026-05-05 |
| RCUS | Arcus Biosciences, Inc. | 24 | +1 | Laggard | loss narrowed 11% | -12% | — | 84 | 2026-05-05 |
| TLPH | Talphera, Inc. Common Stock | 24 | ±0 | Laggard | loss narrowed 60%↑ | -100% | — | 84 | 2026-05-13 |
| XRAY | DENTSPLY SIRONA Inc. | 24 | ±0 | Laggard | to loss | 0% | +894 bps | 63 | 2026-05-05 |
| AKTX | Akari Therapeutics plc ADR (0.01 USD) | 23 | ±0 | Laggard | 0% | -39% | — | — | 2026-05-19 |
| HAE | Haemonetics Corporation | 23 | ±0 | Laggard | to loss | +5%↑ | -455 bps | 62 | 2026-05-20 |
| MRK | Merck & Co., Inc.GLP-1 / Obesity | 23 | ±0 | Laggard | to loss↓ | +5% | -1387 bps | 70 | 2026-05-04 |
| MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | 23 | ±0 | Laggard | loss narrowed 90% | +41%↑ | +2776 bps | 96 | 2026-05-08 |
| NAII | Natural Alternatives International Inc. | 23 | ±0 | Laggard | loss widened 95%↓ | +23% | +206 bps | 10 | 2026-05-19 |
| RCEL | Avita Medical, Inc. Common Stock | 23 | ±0 | Laggard | loss narrowed 34% | +4%↑ | +1685 bps | 91 | 2026-05-14 |
| SMG | The Scotts Miracle-Gro Company | 23 | ±0 | Laggard | +9% | +3% | +509 bps | 65 | 2026-05-06 |
| TNDM | Tandem Diabetes Care, Inc. | 23 | ±0 | Laggard | loss narrowed 85% | +5%↑ | +999 bps | 37 | 2026-05-07 |
| TPST | Tempest Therapeutics, Inc. Common Stock | 23 | ±0 | Laggard | loss narrowed 20%↑ | -2% | — | 25 | 2026-05-14 |
| UAN | CVR Partners, LP | 23 | ±0 | Laggard | +84% | +26% | +418 bps | 56 | 2026-04-29 |
| BAX | Baxter International Inc. | 22 | ±0 | Laggard | to loss↑ | +3% | -158 bps | 65 | 2026-04-30 |
| BHC | Bausch Health Companies Inc | 22 | ±0 | Laggard | loss widened 999%↓ | +12%↑ | -1026 bps | 20 | 2026-04-30 |
| CBT | Cabot Corporation | 22 | ±0 | Laggard | -25% | -3% | -63 bps | 78 | 2026-05-06 |
| FOSL | Fossil Group, Inc. | 22 | ±0 | Laggard | loss narrowed 97% | -4% | +723 bps | 62 | 2026-05-14 |
| IMNM | Immunome, Inc. | 22 | ±0 | Laggard | loss narrowed 8% | -100% | — | 49 | 2026-05-12 |
| MSAI | MultiSensor AI Holdings, Inc. Common Stock | 22 | ±0 | Laggard | loss widened 779%↓ | +38%↑ | — | 9 | 2026-05-13 |
| SLDB | Solid Biosciences Inc. Common Stock | 22 | ±0 | Laggard | loss widened 24%↓ | -100% | — | 91 | 2026-05-12 |
| SOLS | Solstice Advanced Materials Inc. Common Stock | 22 | ±0 | Laggard | -60% | +3% | — | 45 | 2026-05-06 |
| TNGX | Tango Therapeutics, Inc. | 22 | ±0 | Laggard | loss narrowed 11%↓ | -100% | >+10,000 bps | 98 | 2026-05-13 |
| XCUR | Exicure, Inc. Common Stock | 22 | ±0 | Laggard | to loss | — | — | 6 | 2026-05-29 |
| CCEL | Cryo-Cell International Inc. | 21 | +6 | Laggard | +75%↑ | -2% | -1226 bps | 56 | new filing |
| FF | Future Fuel Corporation | 21 | ±0 | Laggard | loss widened 17%↑ | +82% | -4269 bps | 89 | 2026-05-11 |
| FOCL | EDAP TMS S.A. American Depositary Shares | 21 | ±0 | Laggard | loss widened 42% | +2% | — | — | 2026-05-07 |
| NEOG | Neogen Corp | 21 | ±0 | Laggard | loss widened 60%↓ | -4%↓ | +4050 bps | 62 | 2026-04-09 |
| SLN | Silence Therapeutics Plc American Depository Share | 21 | ±0 | Laggard | loss narrowed 45% | +197% | — | 96 | 2026-05-07 |
| UTMD | Utah Medical Products Inc | 21 | ±0 | Laggard | -11% | -10% | -394 bps | 72 | 2026-05-12 |
| BLCO | Bausch + Lomb Corporation | 20 | ±0 | Laggard | loss narrowed 67% | +9% | +289 bps | 43 | 2026-04-29 |
| ELAN | Elanco Animal Health Incorporated Common Stock | 20 | ±0 | Laggard | -15% | +15%↑ | -1613 bps | 60 | 2026-05-06 |
| ELTX | Elicio Therapeutics, Inc. Common Stock | 20 | ±0 | Laggard | loss narrowed 25% | -100% | — | 8 | 2026-05-11 |
| EMBC | Embecta Corp. Common Stock | 20 | ±0 | Laggard | to loss | -14% | +969 bps | 5 | 2026-05-05 |
| IPHA | Innate Pharma S.A. ADS | 20 | ±0 | Laggard | loss narrowed 10% | -78% | — | 51 | 2026-04-01 |
| LAKE | Lakeland Industries Inc | 20 | — | Laggard | — | — | +226 bps | 79 | 2026-06-09 |
| LHX | L3Harris Technologies, Inc.Defense / Drones | 20 | +1 | Laggard | +33% | -74% | +122 bps | 34 | 2026-04-30 |
| OCUL | Ocular Therapeutix, Inc. | 20 | ±0 | Laggard | loss widened 5%↑ | +1% | <-10,000 bps | 29 | 2026-05-05 |
| PSNL | Personalis, Inc. Common StockBiotech & Genomics | 20 | ±0 | Laggard | loss widened 61%↓ | -25% | -8063 bps | 88 | 2026-05-07 |
| SKIN | SkinHealth Systems Inc. Class A Common Stock | 20 | ±0 | Laggard | loss narrowed 38% | -7% | +1590 bps | 12 | 2026-05-07 |
| USNA | USANA Health Sciences Inc | 20 | ±0 | Laggard | -16%↑ | 0%↓ | -269 bps | 59 | 2026-05-12 |
| BYSI | BeyondSpring Inc. Ordinary Shares | 19 | ±0 | Laggard | to loss↓ | — | — | 24 | 2026-05-13 |
| CMPX | Compass Therapeutics, Inc. Common Stock | 19 | ±0 | Laggard | loss narrowed 17% | — | — | 7 | 2026-05-05 |
| CPIX | Cumberland Pharmaceuticals Inc | 19 | ±0 | Laggard | to loss | -22% | -924 bps | 92 | 2026-05-08 |
| CTKB | Cytek Biosciences, Inc. Common Stock | 19 | ±0 | Laggard | loss widened 67% | +6% | -892 bps | 33 | 2026-05-07 |
| FTV | Fortive Corporation | 19 | ±0 | Laggard | -12% | +8%↑ | -114 bps | 67 | 2026-04-30 |
| GEOS | Geospace Technologies Corporation Common Stock | 19 | -1 | Laggard | loss widened 12% | +10% | -2710 bps | 6 | 2026-05-08 |
| HUMA | Humacyte, Inc. Common Stock | 19 | +5 | Laggard | to loss↓ | -4% | — | 17 | 2026-05-13 |
| IVF | INVO Fertility, Inc. Common Stock | 19 | ±0 | Laggard | loss narrowed 73% | +23% | — | 5 | 2026-06-22 |
| LYB | LyondellBasell Industries N.V. Class A | 19 | ±0 | Laggard | -30% | -6% | -422 bps | 76 | 2026-05-01 |
| ACHC | Acadia Healthcare Company, Inc. | 18 | ±0 | Laggard | -44% | +8%↑ | -3982 bps | 98 | 2026-04-30 |
| BDX | Becton, Dickinson and Co. | 18 | ±0 | Laggard | to loss | -11%↓ | -24 bps | 27 | 2026-05-07 |
| BIIB | Biogen Inc. Common Stock | 18 | ±0 | Laggard | +31% | +2% | -152 bps | 76 | 2026-04-29 |
| CPHI | China Pharma Holdings, Inc. | 18 | ±0 | Laggard | loss narrowed 83%↑ | -13% | — | 26 | 2026-05-15 |
| FSI | Flexible Solutions International, Inc. | 18 | ±0 | Laggard | loss widened 0%↑ | +11% | -166 bps | 53 | 2026-05-15 |
| IART | Integra LifeSciences Holdings | 18 | ±0 | Laggard | loss narrowed 82% | +2% | -2891 bps | 91 | 2026-05-05 |
| KPTI | Karyopharm Therapeutics Inc. | 18 | ±0 | Laggard | loss narrowed 55% | +17% | +2796 bps | 70 | 2026-05-14 |
| MMM | 3M Company | 18 | ±0 | Laggard | -40% | +1%↓ | +47 bps | 45 | 2026-04-21 |
| ABEO | Abeona Therapeutics Inc. Common Stock | 17 | ±0 | Laggard | loss widened 25% | — | — | 76 | 2026-05-13 |
| ACNT | Ascent Industries Co. Common Stock | 17 | ±0 | Laggard | loss narrowed 9% | -21% | -1146 bps | 42 | 2026-05-06 |
| ARQ | Arq, Inc. Common Stock | 17 | ±0 | Laggard | to loss | +7% | -4617 bps | 16 | 2026-05-06 |
| FTRE | Fortrea Holdings Inc. Common Stock | 17 | ±0 | Laggard | loss narrowed 96%↑ | -2% | +1086 bps | 68 | 2026-05-05 |
| ICL | ICL Group Ltd. | 17 | ±0 | Laggard | -44% | +5% | -322 bps | 42 | 2026-03-11 |
| INMD | InMode Ltd. Ordinary Shares | 17 | ±0 | Laggard | -36% | -6% | -546 bps | 66 | 2026-02-10 |
| ITOC | iTonic Holdings Ltd Class A Ordinary Shares | 17 | ±0 | Laggard | loss widened 512% | +17% | — | — | 2026-03-30 |
| LRMR | Larimar Therapeutics, Inc. Common Stock | 17 | ±0 | Laggard | loss widened 154% | — | — | 75 | 2026-05-14 |
| AHCO | AdaptHealth Corp. Common Stock | 16 | ±0 | Laggard | loss widened 140% | +5% | -505 bps | 59 | 2026-05-05 |
| BNGO | Bionano Genomics, Inc. Common Stock | 16 | ±0 | Laggard | loss narrowed 34% | +4% | >+10,000 bps | 27 | 2026-05-13 |
| BYAH | Park Ha Biological Technology Co., Ltd. Ordinary Shares | 16 | ±0 | Laggard | to loss | +6% | — | 2 | 2026-03-02 |
| CADL | Candel Therapeutics, Inc. Common Stock | 16 | ±0 | Laggard | to loss↓ | 0% | — | 93 | 2026-05-14 |
| CUPR | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | 16 | +2 | Laggard | loss widened 165% | +3% | — | 59 | 2026-04-27 |
| FLGT | Fulgent Genetics, Inc. Common Stock | 16 | ±0 | Laggard | loss widened 116% | -3%↓ | -847 bps | 23 | 2026-05-01 |
| FULC | Fulcrum Therapeutics, Inc. Common Stock | 16 | ±0 | Laggard | loss narrowed 11% | — | — | 7 | 2026-04-27 |
| KPRX | Kiora Pharmaceuticals, Inc. Common Stock | 16 | ±0 | Laggard | loss widened 12% | — | — | 76 | 2026-05-08 |
| KROS | Keros Therapeutics, Inc. Common Stock | 16 | ±0 | Laggard | to loss↓ | -100%↓ | <-10,000 bps | 14 | 2026-05-14 |
| MLAB | Mesa Laboratories Inc | 16 | ±0 | Laggard | loss widened 645% | -12% | +59 bps | 67 | 2026-06-03 |
| NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | 16 | ±0 | Laggard | loss widened 18% | +2% | <-10,000 bps | 45 | 2026-05-07 |
| AVTR | Avantor, Inc. | 15 | ±0 | Laggard | -33%↑ | 0%↑ | -2073 bps | 40 | 2026-04-29 |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | 15 | ±0 | Laggard | loss narrowed 0% | -100% | — | 71 | 2026-05-05 |
| DNLI | Denali Therapeutics Inc. Common Stock | 15 | ±0 | Laggard | loss narrowed 12%↑ | — | — | 79 | 2026-05-07 |
| ENTX | Entera Bio Ltd. Ordinary Shares | 15 | ±0 | Laggard | +17%↑ | -100% | — | 81 | 2026-05-08 |
| ENVB | Enveric Biosciences, Inc. Common Stock | 15 | ±0 | Laggard | loss narrowed 11%↑ | -7% | — | 6 | 2026-05-15 |
| HRTX | Heron Therapeutics, Inc. | 15 | ±0 | Laggard | to loss | -11%↓ | -453 bps | 6 | 2026-05-11 |
| HURA | TuHURA Biosciences, Inc. Common Stock | 15 | ±0 | Laggard | loss narrowed 13% | — | — | 98 | 2026-05-15 |
| LGVN | Longeveron Inc. Common Stock | 15 | -1 | Laggard | loss narrowed 44% | +4%↑ | — | 63 | 2026-05-13 |
| SCL | Stepan Co. | 15 | ±0 | Laggard | to loss | +2%↓ | -351 bps | 68 | 2026-05-06 |
| VHI | Valhi, Inc. | 15 | ±0 | Laggard | -88% | +4%↑ | -866 bps | 48 | 2026-05-07 |
| ZJYL | JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares | 15 | ±0 | Laggard | -50% | -12% | -1254 bps | 18 | 2026-02-10 |
| ASIX | AdvanSix Inc. | 14 | ±0 | Laggard | to loss | +7% | -597 bps | 71 | 2026-05-08 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 14 | ±0 | Laggard | loss narrowed 12%↑ | -100% | — | 65 | 2026-05-12 |
| EMN | Eastman Chemical Company | 14 | ±0 | Laggard | -41%↑ | -5% | -671 bps | 49 | 2026-05-01 |
| KODK | EASTMAN KODAK COMPANY | 14 | -1 | Laggard | loss widened 75% | +7% | +370 bps | 59 | 2026-05-07 |
| MDWD | MediWound Ltd. | 14 | ±0 | Laggard | loss widened 81% | +13% | <-10,000 bps | 35 | 2026-03-05 |
| MEOH | Methanex Corp | 14 | ±0 | Laggard | -61% | -4% | +228 bps | 75 | 2026-03-05 |
| ROIV | Roivant Sciences Ltd. Common Shares | 14 | -1 | Laggard | to profit | — | — | 90 | 2026-05-20 |
| STOK | Stoke Therapeutics, Inc. Common Stock | 14 | ±0 | Laggard | to loss | -96%↓ | <-10,000 bps | 47 | 2026-05-07 |
| TFX | Teleflex Incorporated | 14 | ±0 | Laggard | to loss↑ | +32% | -555 bps | 83 | 2026-05-07 |
| TROX | TRONOX LIMITED CL A ORDINARY SHARES | 14 | ±0 | Laggard | loss narrowed 7% | +3% | -1183 bps | 56 | 2026-05-07 |
| VSTM | Verastem, Inc. | 14 | ±0 | Laggard | loss narrowed 52% | — | — | 39 | 2026-05-07 |
| CNTB | Connect Biopharma Holdings Limited Ordinary Shares | 13 | ±0 | Laggard | loss widened 79%↓ | — | — | 52 | 2026-05-12 |
| COTY | COTY INC | 13 | ±0 | Laggard | loss widened 0% | -1% | -474 bps | 37 | 2026-05-05 |
| DNA | Ginkgo Bioworks Holdings, Inc. | 13 | ±0 | Laggard | loss narrowed 17% | -60% | -1239 bps | 30 | 2026-05-07 |
| FEED | ENvue Medical, Inc. Common Stock | 13 | ±0 | Laggard | to loss | -36%↓ | — | 5 | 2026-05-18 |
| KRO | Kronos Worldwide, Inc. | 13 | +1 | Laggard | to loss | +4%↑ | -1079 bps | 75 | 2026-05-06 |
| MOS | The Mosaic Company | 13 | ±0 | Laggard | to loss | +14% | -623 bps | 33 | 2026-05-11 |
| OGN | Organon & Co. | 13 | -1 | Laggard | +67% | -4% | -196 bps | 92 | 2026-05-04 |
| OPTX | Syntec Optics Holdings, Inc. Class A Common Stock | 13 | ±0 | Laggard | to loss | -8% | -443 bps | 96 | 2026-05-15 |
| PTCT | PTC Therapeutics, Inc. | 13 | ±0 | Laggard | to loss↓ | -77%↓ | -4728 bps | 59 | 2026-05-07 |
| RVMD | Revolution Medicines, Inc. Common StockBiotech & Genomics | 13 | ±0 | Laggard | loss widened 103%↓ | — | — | 90 | 2026-05-06 |
| ADUR | Aduro Clean Technologies Inc. Common Stock | 12 | ±0 | Laggard | loss widened 23% | -31% | — | 48 | 2025-08-27 |
| EDSA | Edesa Biotech, Inc. Common Shares | 12 | ±0 | Laggard | loss widened 63%↓ | -100% | — | 99 | 2026-05-14 |
| LEGN | Legend Biotech Corporation American Depositary Shares | 12 | ±0 | Laggard | to loss | — | — | 61 | 2026-03-10 |
| NN | NextNav Inc. Common Stock | 12 | ±0 | Laggard | loss narrowed 73% | -35% | — | 37 | 2026-05-14 |
| NRIX | Nurix Therapeutics, Inc. Common stock | 12 | -8 | Laggard | loss widened 56%↓ | -79%↓ | <-10,000 bps | 77 | 2026-07-09 |
| TOMZ | TOMI Environmental Solutions, Inc. | 12 | ±0 | Laggard | loss widened 300% | +5%↑ | — | 30 | 2026-05-08 |
| BDTX | Black Diamond Therapeutics, Inc. Common Stock | 11 | ±0 | Laggard | to loss↓ | -100% | — | 22 | 2026-05-07 |
| EYPT | EyePoint, Inc. Common Stock | 11 | ±0 | Laggard | loss widened 52% | -97%↓ | — | 31 | 2026-05-07 |
| FEIM | Frequency Electronics, Inc.Space Economy | 11 | -9 | Laggard | to loss↓ | — | — | 72 | new filing |
| GPRO | GoPro, Inc. | 11 | ±0 | Laggard | loss widened 67% | -26% | +232 bps | 11 | 2026-05-11 |
| HSCS | HeartSciences Inc. Common Stock | 11 | ±0 | Laggard | loss narrowed 75%↑ | — | — | 32 | 2026-03-16 |
| IMNN | Imunon, Inc. Common Stock | 11 | ±0 | Laggard | loss widened 200% | 0% | — | 12 | 2026-05-12 |
| KRRO | Korro Bio, Inc. Common Stock | 11 | ±0 | Laggard | loss narrowed 32% | -100%↓ | — | 84 | 2026-05-07 |
| MDAI | Spectral AI, Inc. Class A Common Stock | 11 | ±0 | Laggard | to loss | -40%↑ | -3935 bps | 57 | 2026-05-13 |
| MGX | Metagenomi Therapeutics, Inc. Common Stock | 11 | ±0 | Laggard | loss narrowed 10% | -70%↓ | <-10,000 bps | 25 | 2026-05-11 |
| NTRB | Nutriband Inc. Common Stock | 11 | ±0 | Laggard | loss narrowed 17% | -35% | — | 24 | 2026-06-11 |
| OEC | Orion S.A. | 11 | ±0 | Laggard | to loss↑ | -4% | -395 bps | 67 | 2026-05-06 |
| SER | Serina Therapeutics, Inc. | 11 | ±0 | Laggard | loss widened 18%↑ | — | — | 32 | 2026-05-14 |
| TMCI | Treace Medical Concepts, Inc. Common Stock | 11 | ±0 | Laggard | loss widened 12% | -10%↓ | -208 bps | 93 | 2026-05-08 |
| VBIO | Valion Bio, Inc. Common Stock | 11 | ±0 | Laggard | loss narrowed 12% | +16%↑ | — | — | 2026-05-14 |
| XNCR | Xencor, Inc. | 11 | ±0 | Laggard | loss widened 159%↓ | -86%↓ | -8673 bps | 89 | 2026-05-06 |
| ABVX | Abivax SA American Depositary Shares | 10 | ±0 | Laggard | loss widened 81% | -90% | — | 70 | 2026-03-23 |
| AVTX | Avalo Therapeutics, Inc. Common Stock | 10 | ±0 | Laggard | loss narrowed 22% | -100%↓ | — | 74 | 2026-05-13 |
| BNTX | BioNTech SE American Depositary Share | 10 | ±0 | Laggard | loss widened 70% | +4% | -118 bps | 38 | 2026-05-05 |
| CC | The Chemours Company | 10 | ±0 | Laggard | loss widened 533%↓ | +1% | -619 bps | 67 | 2026-05-05 |
| LENZ | LENZ Therapeutics, Inc. Common Stock | 10 | ±0 | Laggard | loss widened 149% | — | — | 5 | 2026-05-11 |
| MOLN | Molecular Partners AG American Depositary Shares | 10 | ±0 | Laggard | loss widened 4% | -100% | — | 43 | 2026-03-12 |
| PFE | Pfizer Inc. | 10 | ±0 | Laggard | -10% | +5%↑ | +66 bps | 48 | 2026-05-05 |
| SVRA | Savara Inc. | 10 | ±0 | Laggard | loss widened 25% | -100% | — | 45 | 2026-05-12 |
| SYPR | Sypris Solutions Inc | 10 | ±0 | Laggard | loss widened 350%↓ | -13% | -1178 bps | 15 | 2026-05-19 |
| VNDA | Vanda Pharmaceuticals Inc. | 10 | ±0 | Laggard | loss widened 64% | +3%↓ | -3765 bps | 25 | 2026-05-07 |
| ZBIO | Zenas BioPharma, Inc. Common Stock | 10 | ±0 | Laggard | loss widened 82% | — | — | 92 | 2026-05-13 |
| ADGM | Adagio Medical Holdings, Inc Common Stock | 9 | ±0 | Laggard | loss narrowed 39%↑ | — | — | 14 | 2026-05-12 |
| AMIX | Autonomix Medical, Inc. Common Stock | 9 | ±0 | Laggard | — | — | — | 8 | 2026-05-27 |
| BCHT | Birchtech Corp. | 9 | ±0 | Laggard | loss widened 200% | +32% | +2238 bps | — | 2026-05-13 |
| FBRX | Forte Biosciences, Inc. Common Stock | 9 | ±0 | Laggard | loss narrowed 9% | -50% | — | 90 | 2026-05-11 |
| LITS | Lite Strategy, Inc. Common Stock | 9 | ±0 | Laggard | loss widened 69% | — | — | 26 | 2026-05-13 |
| LXFR | Luxfer Holdings PLC Ordinary Shares | 9 | ±0 | Laggard | -35% | -14%↓ | -213 bps | 61 | 2026-04-28 |
| ORKA | Oruka Therapeutics, Inc. Common StockBiotech & Genomics | 9 | ±0 | Laggard | loss widened 156%↑ | — | — | 98 | 2026-05-13 |
| PRAX | Praxis Precision Medicines, Inc. Common StockBiotech & Genomics | 9 | +1 | Laggard | loss narrowed 3% | -100% | — | 57 | 2026-05-07 |
| QDEL | QuidelOrtho Corporation Common Stock | 9 | ±0 | Laggard | loss widened 611% | -11% | -3086 bps | 11 | 2026-05-06 |
| RVP | Retractable Technologies, Inc | 9 | ±0 | Laggard | loss narrowed 60% | -13% | +654 bps | 49 | 2026-05-15 |
| SYRE | Spyre Therapeutics, Inc. Common Stock | 9 | ±0 | Laggard | — | — | — | 98 | 2026-05-05 |
| CLDX | Celldex Therapeutics, Inc | 8 | ±0 | Laggard | loss widened 46% | -98% | — | 88 | 2026-05-07 |
| CRVO | CervoMed Inc. Common Stock | 8 | ±0 | Laggard | loss widened 54% | -100%↓ | — | 8 | 2026-05-15 |
| HBIO | Harvard Bioscience Inc | 8 | ±0 | Laggard | loss narrowed 32% | -5% | +5854 bps | 61 | 2026-05-12 |
| HIND | Vyome Holdings, Inc. Common Stock | 8 | ±0 | Laggard | to loss↓ | -84%↓ | — | 24 | 2026-05-12 |
| IRD | Opus Genetics, Inc. Common Stock | 8 | ±0 | Laggard | loss widened 212% | -51% | >+10,000 bps | 90 | 2026-05-12 |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | 8 | ±0 | Laggard | -58% | -25% | -246 bps | 52 | 2026-05-06 |
| SRPT | Sarepta Therapeutics,, Inc. Common StockBiotech & Genomics | 8 | ±0 | Laggard | to profit | -46%↓ | +316 bps | 30 | 2026-05-06 |
| TANH | Tantech Holdings Ltd. Class A Common Shares | 8 | ±0 | Laggard | loss widened 78% | -11% | -4110 bps | 10 | 2026-05-14 |
| TIL | Instil Bio, Inc. Common Stock | 8 | ±0 | Laggard | loss narrowed 86% | — | — | 57 | 2026-05-15 |
| VALN | Valneva SE American Depositary Shares | 8 | ±0 | Laggard | loss widened 16% | -10% | -5484 bps | 11 | 2026-03-17 |
| WHWK | Whitehawk Therapeutics, Inc. Common Stock | 8 | ±0 | Laggard | to loss↓ | -100% | — | 87 | 2026-05-07 |
| XBIT | XBiotech Inc | 8 | ±0 | Laggard | loss narrowed 50% | -100% | — | 40 | 2026-05-14 |
| XENE | Xenon Pharmaceuticals Inc | 8 | ±0 | Laggard | loss widened 41% | -100% | — | 94 | 2026-05-07 |
| ARAY | Accuray Incorporated | 7 | ±0 | Laggard | loss widened 800%↓ | -7% | -137 bps | 6 | 2026-05-06 |
| ARVN | Arvinas, Inc | 7 | ±0 | Laggard | to loss↓ | -92%↓ | <-10,000 bps | 21 | 2026-05-11 |
| ATPC | Agape ATP Corporation Common Stock | 7 | ±0 | Laggard | loss widened 371% | -5%↓ | — | 11 | 2026-05-15 |
| CELZ | Creative Medical Technology Holdings, Inc. Common Stock | 7 | ±0 | Laggard | to loss↓ | -100%↓ | — | 10 | 2026-05-08 |
| CTXR | Citius Pharmaceuticals Inc. Common | 7 | ±0 | Laggard | loss narrowed 25%↓ | — | — | 15 | 2026-05-15 |
| CYCN | Cyclerion Therapeutics, Inc. Common Stock | 7 | -1 | Laggard | loss widened 36% | -100%↓ | — | 98 | 2026-05-12 |
| DNTH | Dianthus Therapeutics, Inc. Common Stock | 7 | ±0 | Laggard | loss widened 4% | -79%↑ | — | 97 | 2026-05-05 |
| HUN | Huntsman Corporation | 7 | ±0 | Laggard | loss widened 933% | +1% | -424 bps | 52 | 2026-05-01 |
| NGNE | Neurogene, Inc. Common Stock | 7 | ±0 | Laggard | loss widened 29%↓ | — | — | 97 | 2026-05-12 |
| NTHI | NeOnc Technologies Holdings, Inc. Common Stock | 7 | ±0 | Laggard | loss narrowed 82%↑ | -100% | — | 8 | 2026-05-15 |
| OSUR | OraSure Technologies Inc | 7 | ±0 | Laggard | loss widened 52%↑ | -7%↑ | -4449 bps | 88 | 2026-05-08 |
| SMMT | Summit Therapeutics Inc. Common Stock | 7 | ±0 | Laggard | loss widened 167%↑ | — | — | 30 | 2026-04-30 |
| ARTV | Artiva Biotherapeutics, Inc. Common Stock | 6 | ±0 | Laggard | loss widened 14% | — | — | 97 | 2026-05-08 |
| AYTU | AYTU BioPharma, Inc. Common Stock | 6 | ±0 | Laggard | to loss↓ | -33% | -2122 bps | 30 | 2026-05-13 |
| EBS | Emergent Biosolutions, Inc. | 6 | ±0 | Laggard | -94% | -30%↓ | +1918 bps | 24 | 2026-05-01 |
| MIND | MIND Technology, Inc. Common Stock (DE) | 6 | ±0 | Laggard | loss widened 999%↓ | +22% | -378 bps | 12 | 2026-06-11 |
| NGVT | Ingevity Corporation | 6 | ±0 | Laggard | +196% | -9% | +1276 bps | 69 | 2026-05-07 |
| PRGO | PERRIGO COMPANY PLC | 6 | ±0 | Laggard | loss widened 999%↓ | -7% | -4185 bps | 23 | 2026-05-06 |
| SCLX | Scilex Holding Company Common Stock | 6 | -1 | Laggard | loss widened 178%↑ | +72% | <-10,000 bps | 21 | 2026-05-20 |
| STRO | Sutro Biopharma, Inc. | 6 | ±0 | Laggard | loss widened 223% | -17% | >+10,000 bps | 95 | 2026-05-14 |
| UNCY | Unicycive Therapeutics, Inc. Common Stock | 6 | ±0 | Laggard | loss widened 198% | -29% | — | 38 | 2026-05-12 |
| VKTX | Viking Therapeutics, IncGLP-1 / ObesityBiotech & Genomics | 6 | ±0 | Laggard | loss widened 234% | — | — | 71 | 2026-04-30 |
| ZYME | Zymeworks Inc. | 6 | ±0 | Laggard | loss widened 97%↓ | -91% | -658 bps | 54 | 2026-05-07 |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 5 | +1 | Laggard | loss widened 83% | -93%↓ | <-10,000 bps | 30 | 2026-05-07 |
| AZTR | Azitra Inc | 5 | ±0 | Laggard | loss widened 9%↑ | — | — | 9 | 2026-05-13 |
| CAPR | Capricor Therapeutics Inc | 5 | ±0 | Laggard | loss widened 11% | -8% | — | 32 | 2026-05-13 |
| CTMX | CytomX Therapeutics, Inc. | 5 | ±0 | Laggard | to loss | -80% | <-10,000 bps | 34 | 2026-05-07 |
| KYNB | Kyntra Bio, Inc. Common Stock | 5 | -1 | Laggard | to loss↓ | +36% | — | 30 | 2026-05-12 |
| MTNB | Matinas BioPharma Holdings, Inc. | 5 | +1 | Laggard | loss narrowed 9% | — | — | 10 | 2026-05-08 |
| OLN | Olin Corp. | 5 | ±0 | Laggard | to loss↓ | -4%↓ | -545 bps | 46 | 2026-05-08 |
| OPK | Opko Health Inc. | 5 | ±0 | Laggard | loss narrowed 30% | -17% | +401 bps | 46 | 2026-04-28 |
| PVLA | Palvella Therapeutics, Inc. Common Stock | 5 | ±0 | Laggard | loss widened 62%↓ | -100% | — | 77 | 2026-05-07 |
| RGNX | REGENXBIO Inc. | 5 | ±0 | Laggard | to loss↓ | -93% | <-10,000 bps | 27 | 2026-05-14 |
| SIGA | SIGA Technologies Inc. | 5 | ±0 | Laggard | loss widened 400% | -11% | -2491 bps | 13 | 2026-05-07 |
| SRTS | Sensus Healthcare, Inc | 5 | ±0 | Laggard | loss widened 0% | -59% | -5982 bps | 19 | 2026-05-13 |
| VRAX | Virax Biolabs Group Limited Ordinary Shares | 5 | ±0 | Laggard | loss narrowed 52% | -96% | — | 12 | 2026-07-06 |
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | 4 | ±0 | Laggard | to loss | -39% | <-10,000 bps | 38 | 2026-04-24 |
| BON | Bon Natural Life Limited Class A Ordinary Shares | 4 | ±0 | Laggard | to loss | -22% | -1655 bps | 21 | 2026-01-23 |
| CATX | Perspective Therapeutics, Inc. | 4 | ±0 | Laggard | loss widened 0% | +11% | — | 75 | 2026-05-11 |
| DAIO | Data I/O Corp | 4 | ±0 | Laggard | loss widened 750% | -47%↓ | -3075 bps | 50 | 2026-05-15 |
| DOW | Dow Inc. | 4 | ±0 | Laggard | loss widened 68% | -6% | -714 bps | 65 | 2026-04-24 |
| TCRT | Alaunos Therapeutics, Inc. Common Stock | 4 | ±0 | Laggard | loss narrowed 12% | -100%↓ | — | 25 | 2026-05-15 |
| VERU | Veru Inc. | 4 | ±0 | Laggard | loss widened 140%↑ | -100% | — | 47 | 2026-05-13 |
| AEHR | Aehr Test Systems | 3 | ±0 | Laggard | loss widened 400% | -44%↓ | -3579 bps | 98 | 2026-04-08 |
| AIM | AIM ImmunoTech Inc. | 3 | ±0 | Laggard | loss widened 999% | +38% | — | 4 | 2026-05-15 |
| BGLC | BioNexus Gene Lab Corp Common stock | 3 | ±0 | Laggard | loss widened 543% | -99%↓ | — | 9 | 2026-05-15 |
| BMRA | BIOMERICA INC | 3 | ±0 | Laggard | loss widened 633% | -12% | — | 17 | 2026-04-13 |
| BRNS | Barinthus Biotherapeutics plc American Depositary Shares | 3 | ±0 | Laggard | loss narrowed 71%↑ | -100% | — | 33 | 2026-04-30 |
| CLNN | Clene Inc. Common Stock | 3 | ±0 | Laggard | loss widened 667% | -81% | — | 70 | 2026-05-14 |
| COGT | Cogent Biosciences, Inc. Common Stock | 3 | ±0 | Laggard | loss widened 2% | -100% | — | 50 | 2026-05-05 |
| EPC | Edgewell Personal Care Company | 3 | ±0 | Laggard | to loss | -11% | -739 bps | 91 | 2026-05-06 |
| FMC | FMC Corporation | 3 | ±0 | Laggard | loss widened 999% | -4%↑ | -6337 bps | 25 | 2026-04-30 |
| GLUE | Monte Rosa Therapeutics, Inc. Common Stock | 3 | ±0 | Laggard | to loss | -95% | <-10,000 bps | 50 | 2026-05-07 |
| PCSA | Processa Pharmaceuticals, Inc. Common | 3 | +1 | Laggard | loss widened 330% | — | — | 17 | 2026-05-07 |
| SXTC | China SXT Pharmaceuticals, Inc. Class A Ordinary Shares | 3 | -31 | Laggard | loss widened 293% | -35% | — | 3 | 2026-07-01 |
| TRDA | Entrada Therapeutics, Inc. Common Stock | 3 | ±0 | Laggard | loss widened 126% | -96% | — | 17 | 2026-05-07 |
| WLK | Westlake Corporation | 3 | ±0 | Laggard | loss widened 323% | -7% | -2081 bps | 39 | 2026-05-06 |
| ALEC | Alector, Inc. Common Stock | 2 | ±0 | Laggard | loss narrowed 49% | -72% | <-10,000 bps | 30 | 2026-05-07 |
| ASTC | Astrotech Corporation (DE) Common Stock | 2 | ±0 | Laggard | loss widened 3% | -36% | — | — | 2026-05-13 |
| CELU | Celularity Inc. Class A Common Stock | 2 | ±0 | Laggard | loss widened 47% | -77% | <-10,000 bps | 18 | 2026-04-30 |
| CNEY | CN Energy Group Inc. Class A Ordinary Shares | 2 | ±0 | Laggard | loss narrowed 79% | -30% | — | 72 | 2026-01-30 |
| DCGO | DocGo Inc. Common Stock | 2 | ±0 | Laggard | loss widened 67% | -21%↑ | -6034 bps | 27 | 2026-05-11 |
| GNPX | Genprex, Inc. Common Stock | 2 | ±0 | Laggard | loss widened 146% | — | — | 2 | 2026-05-13 |
| MCRB | Seres Therapeutics, Inc. | 2 | ±0 | Laggard | to loss | — | — | 7 | 2026-05-05 |
| NKTR | Nektar Therapeutics | 2 | ±0 | Laggard | loss widened 658% | +4%↑ | <-10,000 bps | 96 | 2026-05-08 |
| QCLS | Q/C Technologies, Inc. Common Stock | 2 | ±0 | Laggard | loss narrowed 47% | -100% | — | 24 | 2026-05-15 |
| AEMD | AETHLON MEDICAL INC | 1 | ±0 | Laggard | loss narrowed 55% | -100% | — | 4 | 2026-06-10 |
| APVO | Aptevo Therapeutics Inc | 1 | ±0 | Laggard | loss widened 46% | -100% | — | 13 | 2026-05-13 |
| BCAB | BioAtla, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -100% | — | 5 | 2026-05-15 |
| BOLT | Bolt Biotherapeutics, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -98% | — | 20 | 2026-05-12 |
| CANF | Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares | 1 | ±0 | Laggard | to loss | -40% | — | 29 | 2026-03-26 |
| DCOY | Decoy Therapeutics Inc. Common Stock | 1 | ±0 | Laggard | loss widened 306% | — | — | 10 | 2026-05-08 |
| ELAB | PMGC Holdings Inc. Common Stock | 1 | ±0 | Laggard | loss widened 287%↑ | — | — | 2 | 2026-05-15 |
| FCUV | Focus Universal Inc. Common Stock | 1 | ±0 | Laggard | loss widened 771% | -75% | — | 2 | 2026-05-14 |
| GRI | GRI Bio, Inc. Common Stock | 1 | ±0 | Laggard | loss narrowed 72% | — | — | 4 | 2026-05-13 |
| HELP | Cybin Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -100% | — | 42 | 2026-06-29 |
| IMA | ImageneBio, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 428% | — | — | 39 | 2026-05-07 |
| LYEL | Lyell Immunopharma, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 511% | -71% | — | 15 | 2026-05-06 |
| MBRX | Moleculin Biotech, Inc. | 1 | ±0 | Laggard | loss widened 462% | — | — | 12 | 2026-05-14 |
| MODD | Modular Medical, Inc. Common Stock | 1 | -59 | Laggard | loss widened 999% | — | — | 4 | 2026-06-29 |
| NERV | Minerva Neurosciences, Inc | 1 | ±0 | Laggard | loss widened 472% | — | — | 55 | 2026-05-05 |
| NVNO | enVVeno Medical Corporation Common Stock | 1 | ±0 | Laggard | loss widened 999% | -100% | — | 47 | 2026-05-06 |
| NXTC | NextCure, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 379% | -100% | — | 9 | 2026-05-07 |
| NXTS | Nexentis Technologies Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -78% | — | — | 2026-05-14 |
| ONCO | Onconetix, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999% | -79%↓ | — | 1 | 2026-05-13 |
| OSRH | OSR Health, Inc. Common Stock | 1 | ±0 | Laggard | loss narrowed 92% | -36% | — | 17 | 2026-05-13 |
| PTN | Palatin Technologies, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 106% | -56% | — | 12 | 2026-05-13 |
| RNAC | Cartesian Therapeutics, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 115% | -100% | — | 68 | 2026-04-30 |
| SDEV | Stablecoin Development Corporation | 1 | ±0 | Laggard | +135% | — | — | — | 2026-05-15 |
| SNYR | Synergy CHC Corp. Common Stock | 1 | ±0 | Laggard | to loss | -33% | -5730 bps | 2 | 2026-05-14 |
| SPRB | Spruce Biosciences, Inc. Common Stock | 1 | ±0 | Laggard | loss widened 999%↑ | -100% | — | 17 | 2026-05-13 |
| STEX | Streamex Corp. Common Stock | 1 | ±0 | Laggard | loss widened 93% | +8%↑ | — | 5 | 2026-05-14 |
Every US common stock and ADR in the universe is ranked on fundamental growth from the numbers companies actually filed with the SEC — no analyst estimates, no forward projections. TickerStance reads EDGAR XBRL company facts directly.
To qualify, a company must have at least six quarters of EPS and revenue history available and the most-recent filing must be no older than 200 days. That gate keeps the rankings grounded in current operating conditions rather than stale data.
Two growth factors are computed: recent year-over-year growth (latest quarter vs the same quarter last year) blended with a three-year trend score. Both factors are percentile-ranked universe-wide so a rank of 90 means the company grows faster than 90% of its peers, regardless of absolute size. The two factor percentiles are then combined into a single 1-99 fundamentals rank.
Operating margin is tracked as context — a company whose margins are expanding while growing revenue is a stronger story than one shrinking margins to buy growth — but margin level is not a direct rank input. Industries, sectors, and themes inherit their rank from the median of their members, so a strong cluster is one where most constituent companies score well, not just a few outliers.
The RS overlap metric shows what share of a cluster's eligible companies sit in the top relative-strength quintile (6M RS rank ≥ 80). When a fundamentally strong group also carries broad price leadership, it has both the earnings story and the institutional sponsorship — the combination that historically precedes sustained outperformance.
Every US common stock and ADR with sufficient SEC filing history gets a 1-99 fundamentals rank: EPS and revenue growth factors are computed from filed XBRL data, percentile-ranked across the universe, and blended. Ranks of 90+ are Leaders, 70-89 Strong, 30-69 Average, below 30 Laggards. Industries, sectors, and themes are then ranked by their members' median rank.
SEC EDGAR XBRL company facts — the numbers companies actually filed. No analyst estimates, no forward guidance, no third-party data vendor.
Sign-aware: a narrowed loss counts as improvement, a widened loss as deterioration, a swing to profit as a turnaround. Conventional percent math misreads losses (a loss shrinking from -$0.12 to -$0.07 is improvement, not "down 42%"), so the table says "loss narrowed 42%" instead of printing a misleading percentage.
The change in a group's median fundamentals rank versus 15 and 30 trading days ago — the classic "improving group" read. Positive means the group is gaining rank. Dashes mean the history window isn't available yet.
Once per US trading day after the close. The as-of date in the header is the snapshot date.